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Abstract
The neural crest is a transient collection of cell, termed neural crest cells (NCCs), 
which develop during neurulation at the outer extremities of the neural folds 
between surface ectoderm and the developing neural tube. NCCs delaminate from 
the crest and migrate throughout the developing embryo and differentiate into many 
cell types such as melanocytes, peripheral neurons, osteocytes, muscle cells and 
enteric neurons and glia.
With the use of a lineage tracing system (Wtl-Cre X Rosa26R mouse line) it was 
previously found that cells derived from Wtl-expressing cells have contributed to 
the post-natal enteric nervous system (ENS), indicating that Wtl must have been 
expressed in progenitor cells of the ENS during embryonic development. The goal 
of this project was therefore to identify when and where Wtl is expressed during 
this process.
Data from immunofluorescence studies revealed that Wtl is transiently expressed in 
Sox 10-expressing NCCs when they first begin their migration from the neural crest, 
at E8.5 in the mouse. Wtl is then down-regulated in NCCs before they enter the 
foregut at E9.5. This data has been supported by in situ hybridisation studies, where 
Wtl has been found in cells of the neural crest at the same time point (E8.5) but 
Wtl mRNA was not shown to be present at any embryonic stage later than this.
In vitro investigations were carried out in order to characterise Wtl in vagal level 
NCCs, as it is NCCs from this region (opposite somites 1-7) and the sacral neural 
crest (caudal to somite 28) which have been established as the origin of the ENS. 
NCCs were characterised by morphology and marker expression over a time-period 
of 7 days. The results from immunofluorescence experiments revealed co­
expression of Wtl and NCC markers, SoxlO, up to 96 horn's in culture. After this 
time-point it was no longer possible to detect these proteins in cultured explants. 
The neuronal marker pill Tubulin was detected from 48 hour’s and was still found to 
be expressed at high levels after 96 hour's when Wtl and NCC markers had ceased 
to be expressed, suggesting differentiation of NCCs.
Migration assays whereby the rate of migration was determined in NCCs in culture 
over a period of 48 hours revealed a mean migration rate of 6pm/hour. These data 
are relevant for future siRNA Wtl knock-down experiments in NCCs in vitro to 
investigate the effect of loss of Wtl function on migration rates, cell morphology, 
and expression patterns following preliminary experiments carried out on kidney 
stem cells.
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Chapter 1
Introduction
i
The following chapter will describe the background to the work I have canied out 
during this project looking at the expression of the Wilms’ tumour gene (Wtl) and 
its unexpected detection in the developing enteric nervous system (ENS) using 
lineage tracing techniques. I will discuss the development of the ENS from its 
origin in the neural crest and specific markers that are expressed during ENS 
development. While these markers have important functions, they can also be used 
as a tool for visualising cells of the neural crest and developing ENS and so have 
been employed for this purpose throughout my studies. I will also discuss the 
multifaceted Wtl protein, its discovery, structure and function, and will attempt to 
establish the link between Wtl and the ENS which serves as the basis for my 
research.
1.1 The enteric nervous system and its origin
The enteric nervous system (ENS) is unique in its ability to control gut behaviour 
without the direct control of the central nervous system (brain and spinal cord). It 
is therefore regarded as a branch of the autonomic nervous system (ANS). The 
ENS consists of enteric ganglia, which contain both neurons and supporting cells, 
known as glia. There are two major types of enteric ganglia found in different 
locations within the intestinal tract. These are the myenteric plexus (of Auerbach) 
and the submucosal plexus (of Meissner) (Furness 2006). Axons originating in 
these plexuses innervate all aspects of the digestive tract, controlling the processes 
involved in digestion, such as peristalsis and secretion of enzymes and hormones 
needed for the breakdown and uptake of ingested foodstuff from accessory organs 
such as the biliary system and the pancreas (Furness 2006).
2
The significance of studying the enteric nervous system (ENS) stems from 
congenital disorders of the intestinal tract, which occur due to malformations of the 
ENS. One such disorder is Hirschsprung’s disease, which is found in 1 in 5000 live 
births. This is a congenital disorder usually restricted to the hindgut where it is 
characterised by an absence of enteric ganglia in this area (Whitehouse and 
Kemohan 1948; Amiel and Lyonnet 2001; Heanue and Pachnis 2006). The 
absence of enteric ganglia leads to a condition known as megacolon, which was 
first described by Harald Hirschsprung in 1888. Megacolon arises from the tonic 
contraction of the aganglionic portion of colon, which results in obstruction and 
distension of the more rostral bowel (Amiel and Lyonnet 2001; Heanue and 
Pachnis 2006). The following section describes the ENS and its development from 
the neural crest during embryogenesis thus serving as a foundation for my 
investigation into the embryonic ENS.
Development of the neural crest
The neural crest is a transient collection of cells, termed neural crest cells (NCCs), 
which develop during neurulation at the outer extremity of the neural folds, 
between the surface ectoderm and the developing neural tube (Figure 1.1). These 
cells undergo epithelial-mesenchymal transition (EMT), transforming from static 
epithelial cells into motile mesenchymal cells. After delamination NCCs migrate 
away from the neural crest as neural tube closure ensues (Kalcheim and Burstyn- 
Cohen 2005; Young, Cane et al. 2010). The NCCs migrate, originating along the 
entire length of the neural tube, throughout the developing embryo. NCCs from 
varying levels within the embryo differentiate into a vast number of cell types, 
including the sympathetic and parasympathetic nervous system (ANS) and
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specifically the ENS. They also develop into the pigment cells of the skin, known 
as melanocytes (Stanchina, Baral et al. 2006) and form the craniofacial skeleton. 
The neural crest-derived bones of the skull vault, face and neck differ from the rest 
of the skeleton, which are derived from mesoderm forming from a cartilaginous 
model through the process of endochondrial ossification (Erlebacher, Filvaroff et 
al. 1995; Abzhanov, Rodda et al. 2007). Interestingly, Gans and Northcutt 
hypothesised that the neural crest-derived portion of the head and neck evolved to 
support and protect the ever increasing brain capacity found throughout the 
evolution of vertebrates, from primitive organisms such as lampreys to modern 
man and our relatively large brain (Gans and Northcutt 1983; Kalcheim and 
Burstyn-Cohen 2005).
The neural crest and the development of the enteric nervous system
Many different cell lineages including the ENS are derived from NCCs. In 1954, 
Yntema and Hammond undertook a study to determine the region of neural crest 
specific to the development of the ENS. They ablated specific regions along the 
rostro-caudal axis of neural tube in the chick embryo revealing that removal of the 
neural crest in the vagal region, i.e. opposite somites 1-7, lead to a complete 
deficiency of enteric ganglia along the whole gastrointestinal tract. The conclusion 
from their study was that the vagal region of the neural crest is solely responsible 
for ENS formation (Yntema and Hammond 1954). Interestingly, some twenty 
years later Le Douarin and Teillet conducted chick/quail experiments whereby they 
placed regional quail neural tube grafts into the corresponding region in chick 
embryos. Their work confirmed that vagal level neural crest does indeed contribute 
to ENS development. They further demonstrated that the sacral neural crest also
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contributes to ENS development in the distal portion of the intestinal tract. The 
sacral neural crest lies caudal to somite 28 in the chick, and NCCs from this region 
contribute to enteric ganglia in the hindgut (Le Douarin and Teillet 1973) (Figure 
1.2).
The vagal neural crest is described as the area of the dorsal neural tube laying 
opposite somites 1-7 of the developing embryo i.e. the site of emergence of the 
tenth cranial nerve, Vagus nerve (Le Douarin 2004). Although the vagal neural 
crest has been described as the major contributor to the fonnation of the ENS, and 
this will be discussed in detail, it is important to note that the cells emigrating from 
this level of the neural crest also differentiate into multiple other neural crest- 
derived lineages (Le Douarin 2004; Kuo and Erickson 2010). An overview can be 
seen in (Figure 1.3). The nonnal development of the embryonic heart relies on the 
correct migration of NCCs derived from the cardiac neural crest region around 
somites 1-3. This is a direct overlap with the path of the vagal neural crest 
(opposite somites 1-7) (Le Lievre and Le Douarin 1975; Kirby, Gale et al. 1983; 
Kirby, Tumage et al. 1985; Kirby and Waldo 1995; Le Douarin 2004; Kuo and 
Erickson 2010). The cells in this region migrate to the heart and form the 
aorticopulmonary septum, separating the truncus arteriosus of the developing 
cardiac outflow tract in to the primitive ascending aorta and the pulmonary trunk 
(Kirby, Gale et al. 1983). Cells from the rostral most vagal neural crest also 
develop into bones and musculature of the jaw and neck e.g. Hyoid bone, due to 
their contribution to the caudal most pharyngeal arches (Kuratani and Kirby 1991; 
Couly, Grapin-Botton et al. 1996; Le Douarin 2004; Rupp and Kulesa 2007; Kuo 
and Erickson 2010). The vagal neural crest also contributes to the dermis and
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melanocytes of the skin, sensory and sympathetic ganglia, and peripheral nerves 
and glia (Le Lievre and Le Douarin 1975; Le Douarin 2004; Kuo and Erickson 
2010). With this in mind the contribution of vagal neural crest to the ENS will now 
be discussed in more detail.
Several techniques have been employed to visualise neural crest cells in order to 
track their migratory pathways within the gastrointestinal tract. The DpH-nLacZ 
transgene utilises the human dopamine (3-hydroxylase gene promoter to drive p- 
Galactosidase expression in NCCs. Dopamine P-hydroxylase was chosen due to its 
early expression in gastrointestinal development, before differentiation into enteric 
neurons (Kapur, Yost et al. 1992). Immunohistochemistry techniques were applied 
to studies, which aimed to show NCC migratory dynamics in mouse (Kapur, Yost 
et al. 1992; Young, Hearn et al. 1998). The results from these studies revealed the 
migratory pathways of the vagal population of NCCs were unidirectional along the 
rostro-caudal axis of the gastrointestinal tract (Figure 1.4). However, individual 
NCCs within the vagal population display unique and complicated migratory 
behaviour's, changing both direction and speed as they move along the gut (Young, 
Bergner et al. 2004). NCCs were shown to enter the foregut of the mouse at E9.5. 
They progress along the gut mesenchyme and by El2 were found throughout the 
foregut and the majority of the midgut, completely colonising the caecum. At El 3 
the neural crest cells had migrated as far as the caudal-most one third of the 
hindgut and by El4.5 the entire length of the gastrointestinal tract had been 
colonised with NCCs (Kapur, Yost et al. 1992; Young, Heam et al. 1998). 
However, these studies did not discuss the sacral neural crest contribution during 
ENS development.
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In order to follow the migration of sacral NCCs in the mouse DpH-nLacZ embryos 
were once again used. At El 1.5 P-Gal positive NCCs resided in a dorsal position to 
the hindgut (Anderson, Stewart et al. 2006). Between E12.5 and E14.5 the position 
of P-Gal positive NCCs had moved ventrally and NCCs were found close to the 
urogenital sinus (Kapur 2000) but before El4.5 NCCs were not found within the 
hindgut mesenchyme. By E14.5 vagal level NCCs had colonised the entire hindgut 
and it was at this time point that p-Gal positive sacral NCCs were shown to migrate 
in a caudo-rostral manner within the hindgut (Anderson, Stewart et al. 2006). 
Studies conducted in avian embryos used chick/quail chimeras to distinguish sacral 
level from vagal level NCCs (Pomeranz and Gershon 1990; Bums and Douarin 
1998; Bums, Champeval et al. 2000; Burns and Le Douarin 2001). The findings 
from these studies revealed that sacral NCCs colonise the hindgut once vagal 
NCCs have arrived there. It was also discovered that ablation of the vagal neural 
crest did not impede sacral NCC colonisation of the hindgut, suggesting that sacral 
NCCs are independent of vagal NCCs and do not require the presence of vagal 
NCCs in order to form enteric ganglia within the hindgut. However, sacral NCCs 
were shown to be insufficient to colonise the entire gastrointestinal tract alone and 
so cannot compensate and produce a complete ENS in the absence of vagal NCCs. 
Therefore the ENS does not develop fully in the absence of vagal NCCs and 
aganglionosis occurs (Pomeranz and Gershon 1990; Bums and Douarin 1998; 
Burns, Champeval et al. 2000; Bums and Le Douarin 2001).
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Determination of NCCs along the ENS lineage
The previous sections described the structure and function of the ENS and how the 
origin of ENS was experimentally established i.e. predominantly from the vagal 
and sacral neural crest. It is also important to discuss the determining factors which 
are essential for the proper development of the ENS and what happens when this 
complex system of signalling goes wrong or is altered.
Specific genes are expressed when the neural crest forms and as enteric neurons 
and glia mature. There are many different proteins encoded for by these genes such 
as transcription factors, growth factors and receptors. Each gene/protein has a 
specific function during the development of the ENS. A comprehensive list of 
genes and molecules expressed during ENS development can be found in table 1.1. 
However, they can also be utilised as tools for visualising cells histologically and 
are therefore useful markers when studying ENS development. Thus, several of 
these proteins have been used in immunofluorescence experiments in order to 
locate NCCs, enteric neurons and glia at specific time-points during mouse 
embryonic development throughout this project.
The sequence of events and associated molecular signalling mechanisms involved 
in ENS development have been unravelled by several labs resulting in a good 
general understanding of the process. A general theme running throughout the 
literature shows that the genes and protein expressed earliest in ENS development 
have the most devastating effects if they are inactivated or mutated. As mentioned 
previously the neural crest develops during the process of neurillation, very early 
on in embryonic development. In mouse the neural crest can be detected at
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embryonic day (E) 8 by the expression of Sox 10,, a very early marker for 
uncommitted NCCs (Anderson, Stewart et al. 2006). Sox 10 belongs to a family of 
transcription factors known as Sry-HMG-box (Wegner 1999; Schepers, Teasdale et 
al. 2002). The Sox family of proteins is subdivided into Sox A-H groups and they 
function by binding to DNA via the HMG (high-mobility group) domain. Sox 10 is 
part of the SoxE group (Hong and Saint-Jeannet 2005). Development progresses 
rapidly and within half a day in the mouse (E8.5) NCCs have already begun their 
migration away from the neural crest (Anderson, Stewart et al. 2006). Important 
molecules expressed at this stage include Sox 10, p75 and Phox2b (Young and 
Newgreen 2001; Anderson, Stewart et al. 2006). Deletion of Phox2b or SoxlO 
show the most dramatic ENS phenotypes as complete aganglionosis along the 
entire gastrointestinal tract is observed (Herbarth, Pingault et al. 1998; Southard- 
Smith, Kos et al. 1998; Kapur 1999; Pattyn, Morin et al. 1999; Young and 
Newgreen 2001; Anderson, Stewart et al. 2006) (Figure 1.5, A). As vagal NCCs 
migrate towards the foregut, where they reach the oesophagus at E9.5, in order to 
begin their rostro-caudal journey along the gut tube molecules are expressed in a 
specific sequence, ensuring the correct NCCs end up in the correct place. For 
example, Mash 1, a transcription factor in the bHLH family, is expressed by NCCs 
which form the ENS of the oesophagus (Lo, Guillemot et al. 1994; Young and 
Newgreen 2001; Gershon 2010). When Mashl is knocked out aganglionosis is 
restricted to the oesophagus, while enteric ganglia are present throughout the rest 
of the gut (Lo, Guillemot et al. 1994; Young and Newgreen 2001) (Figure 1.5, B). 
In contrast, the vagal NCCs which will go on to innervate the gut caudal to the 
stomach are highly dependent on GDNF/GFRa/Ret signalling (Chalazonitis, 
Rothman et al. 1998; Hearn, Murphy et al. 1998; Taraviras, Marcos-Gutierrez et al.
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1999; Gershon 2010). Therefore the deletion of any of these molecules produces a 
phenotype whereby aganglionosis occurs caudal to the stomach (Figure 1.5, C) 
(Schuchardt, D'Agati et al. 1994; Moore, Klein et al. 1996; Young and Newgreen 
2001). NCCs migrate and form enteric plexuses readily up to the proximal colon, 
i.e. the caecum, if the aforementioned molecules are expressed, they arrive at the 
proximal colon around El 1.5 in the mouse (Young and Newgreen 2001). Past this 
point NCCs critically require the expression of endothelin-3 (ET-3), a 21 amino 
acid peptide, and its G-protein-coupled seven-transmembrane endothelin-B 
receptor (Ednrb), in order to reach the most distal portions of the large bowel 
(E11.5-E14.5 in mouse) (Baynash, Hosoda et al. 1994; Hosoda, Hammer et al. 
1994; Young, Hearn et al. 2000; Young and Newgreen 2001; Gershon 2010). 
Deletion of either ET-3 or Ednrb leads to aganglionosis of the distal-most large 
intestine (Figure 1.5, D) (Baynash, Hosoda et al. 1994). This is similar to the 
phenotype present in Hirschsprung’s disease (Baynash, Hosoda et al. 1994; 
Gershon 2010).
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1.2 Epithelial to mesenchymal transition, EMT
Epithelial to mesenchymal transition (EMT) is crucial for neural crest cell 
development. EMT is a process by which epithelial cells become motile by 
transforming into mesenchymal cells (Figure 1.6). Conversely, motile 
mesenchymal cells can also transform into epithelial cells. This is known as 
mesenchymal to epithelial transition (MET) (Figure 1.6) (Chaffer, Thompson et al. 
2007). These processes are controlled by transcription factors of the Snail family 
(Nieto, Sargent et al. 1994), Snail transcription factors function by repressing the 
expression of cell adhesion molecules, which are vital in maintaining the structural 
integrity of epithelial cells. E-cadherin has been particularly well described as a 
cell adhesion molecule controlled by Snail transcription factors, such as Slug, in 
the process of all EMTs (Cano, Perez-Moreno et al. 2000). In the following part I 
will delineate why EMT is considered on of the most important processes 
throughout embryonic development (Hay 1995).
The earliest role for EMT is during gastrulation when the primitive streak is 
formed (Duband, Monier et al. 1995; Murray and Gridley 2006; Chaffer, 
Thompson et al. 2007; Hugo, Ackland et al. 2007). As mentioned above, EMT is 
also essential for neural crest development (Figure 1.1). Neural crest cells originate 
as part of the neural plate, which is epithelial in structure. In order to be able to 
migrate as extensively as NCCs are known to do, they have to lose their epithelial 
properties and become motile mesenchymal cells. Immediately after delamination, 
NCC-derived cells migrate away from the dorsal neural tube (Duband, Monier et 
al. 1995; Sakai and Wakamatsu 2005).
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EMT and/or MET occur in various tissues during development of the mammalian 
embryo, including the kidneys and mesothelium. Interestingly, the Wilms’ tumour- 
gene (Wtl) is expressed in both tissues/organs. Therefore, it has been proposed 
that Wtl actively plays a role in EMT and MET processes (Pritchard-Jones, 
Fleming et al. 1990; Annstrong, Pritchard-Jones et al 1993; Moore, Mclnnes et al. 
1999; Carmona, Gonzalez-Iriarte et al. 2001; Wilm, Ipenberg et al. 2005; 
Martinez-Estrada, Lettice et al. 2010),
MET is an important process in kidney formation, which involves the two main 
tissues of the developing kidney, the ureteric bud and the metanephric 
mesenchyme. When the ureteric bud invades the metanephric mesenchyme, which 
expresses Wtl, the mesenchymal cells to undergo MET as a consequence. The 
resulting metanephric mesenchyme-derives cells then form epithelial structures 
which give rise to the nephrons (Figure 1.7) (Vainio and Lin 2002; Chaffer, 
Thompson et al. 2007).
The mesothelium expresses Wtl and is also known to undergo EMT. The 
mesothelium consists of mesothelial cells which form an epithelial monolayer that 
gives a covering to the body cavities of mammals. There are three cavities in the 
developing embryo and these divide the mesothelium into three specific parts. The 
peritoneum surrounds the abdominal cavity and the organs housed within it. The 
pericardium surrounds the heart and mediastinum. The pleura lines the lungs and 
the thoracic cavity. These serosal mesothelial coverings provide protection and 
allow movement of organs against one another without friction (Mutsaers 2002; 
Mutsaers 2004). Investigation into coronary blood vessel development had shown
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that mesothelial cells from an area of the septum transversum, the proepicardium, 
migrate to the heart and undergo EMT, subsequently differentiating into coronary 
blood vessels (Mikawa and Gourdie 1996; Dettman, Denetclaw et al. 1998). A 
similar phenomenon occurs during development of the gut and lung vasculature, 
whereby mesothelial cells of the peritoneum undergo EMT and contribute to the 
smooth muscle component of these vessels (Wilm, Ipenberg et al. 2005; Que, 
Wilm et al. 2008). In order to identify the role of the serosal mesothelium in the 
development of intestinal vasculature, the Cre-LoxP system was employed. 
Specifically, a transgenic mouse line was used in which Cre recombinase was 
placed under control of the human Wtl promoter, to study the lineage of 
embryonic mesothelial cells which express Wtl protein (Wilm, Ipenberg et al. 
2005). Cells marked by Cre activity were found in the vascular smooth muscle of 
the intestine, the heart and the lungs (Wilm, Ipenberg et al. 2005; Que, Wilm et al. 
2008). However, unexpectedly, marked cells were also discovered in the ENS 
along the intestinal tract of adult mice (Figure 1.8) (Wilm, Ipenberg et al. 2005). 
This was a novel finding since the ENS has never before been described as 
developing from Wtl-expressing cells and Wtl is not expressed in the ENS of 
adult mice. In the adult Wtl is restricted to podocytes of the kidney and the 
mesothelium (Rivera and Haber 2005; Wilm, Ipenberg et al, 2005).
1.3 Wilms’ tumour gene, Wtl
Wtl encodes a four C-terminal Cys2-His2 zinc fingered protein with a 
proline/glutamine rich N-tenninal (Call, Glaser et al. 1990; Gessler, Poustka et al. 
1990) (Figure 1.9). The structure of the protein encoded for by Wtl, and its 
localisation in the nucleus indicated that Wtl protein functions as a transcription
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factor (Rauscher, Morris et al. 1990; Morris, Madden et al. 1991; Pelletier, 
Schalling et al. 1991; Bickmore, Oghene et al. 1992). However, it has since been 
discovered that Wtl is also expressed in the cytoplasm (Niksic, Slight et al. 2004). 
Staining observed using immunohistological techniques had at first been 
disregarded as an artefact (Hohenstein and Hastie 2006) but Wtl has since been 
shown to actively shuttle between the nucleus and cytoplasm (Niksic, Slight et al. 
2004). Further work into cytoplasmic Wtl revealed an interaction with actin 
(Jomgeow, Oji et al. 2006). Actin is part of the cell cytoskeleton and is vital for 
cell movement (Dudnakova, Spraggon et al. 2010). The results from these 
investigations suggest there is also a role for Wtl in the cytoplasm. Although 
further investigation is needed in order to confirm the role of cytoplasmic Wtl, the 
data suggests that Wtl could be an adaptor protein which aids in the transport of 
actin mRNA to its target area (Dudnakova, Spraggon et al. 2010). Wtl has 10 
exons and has been found to have many different isoforms. The resulting isoforms 
are the result of alternative splicing, alternative start sites and RNA editing events 
(Hohenstein and Hastie 2006). Alternative slicing and its significance for Wtl 
function will be discussed in subsequent sections.
The discovery of Wtl
Wtl was discovered by examining the genetic properties of Wilms’ tumour (Call, 
Glaser et al, 1990). Wilms’ tumour, also known as nephroblastoma, is a malignant 
tumour found in the neonatal kidney. Wilms’ tumours arise due to a continuing 
presence of renal stem cells, which remain in a proliferative state instead of either 
becoming terminally differentiating thus ceasing to divide, or dying (Hastie 1994). 
The incidence of this tumour is around 1 in 10,000 children (Matsunaga 1981). A
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deletion in chromosome 11 on the short arm at position pl3 (llpl3) demonstrated 
a genetic predisposition to the development of Wilms’ tumour (Riccardi, Sujansky 
et al. 1978; Francke, Holmes et al. 1979). A proportion of children with Wilms’ 
tumours also suffered from other problems, including aniridia, an abnormality 
found in the eye, genitourinary irregularities, particularly pseudohermaphroditism 
in males, and mental retardation. Due to these corresponding conditions resulting 
from mutations at lip 13, it was termed WAGR syndrome (Wilms’ tumour, 
Aniridia, Genitourinary abnormalities, mental Retardation) (Francke, Holmes et al. 
1979; Hastie 1994). By cloning a sequence of cDNA located at chromosome 1 lpl3 
both Call and Gessler were able to delineate one candidate gene likely to be 
responsible for the development of Wilms’ tumour'. This was the Wilms’ tumour 
gene, Wtl (Call, Glaser et al. 1990; Gessler, Poustka et al. 1990). The following 
section describes the published Wtl expression pattern and function during 
development.
Expression pattern of Wtl in embryonic development
Following the discovery of the Wilms’ tumour gene, Wtl, work began to establish 
an animal model that could be used in the study of Wilms’ tumour', associated 
disorders, and Wtl function. The expression pattern of Wtl was initially 
investigated using in situ hybridisation. Within a few year's of its discovery quite a 
comprehensive catalogue of tissues expressing Wtl had been assembled. Early 
work using Northern blot analysis and in situ hybridisation showed Wtl expression 
in the foetal kidney, the stromal cells and splenic capsule of the spleen, gonads 
(primitive testis and ovaries), and foetal brain of the mouse (Pritchard-Jones, 
Fleming et al. 1990; Park, Schalling et al. 1993). Pritchai'd-Jones also reported the
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expression of Wtl in the developing human kidney. In situ hybridisation data on 
18 week human embryonic kidney showed human WT1 expression becoming 
more restricted as development progressed. The results revealed weak expression 
in the early condensing mesenchyme, stronger expression in the renal vesicle, and 
restriction to podocytes in the maturing glomeruli, where it remains into adulthood 
(Figure 1.6) (Pritchard-Jones, Fleming et al. 1990). Expression of Wtl in the 
developing genitourinary system was found to become specified to the granulosa 
cells of the ovaries, the sertoli cells of the testis, and the myometrium of the uterus 
(Pelletier, Schalling et al. 1991). Armstrong and colleagues made a comprehensive 
investigation using in situ hybridisation. The results revealed Wtl expression in all 
the tissues listed above but also additional tissues including the mesothelial cells 
covering the coelomic cavity, particularly in the region of the heart and gut, the 
spinal cord, roof of the fourth ventricle and body wall musculature. RNA-PCR at 
El2.5 showed low levels of Wtl in the eye and tongue. They also reported that Wtl 
is not expressed prior to E9.0 in the mouse (Armstrong, Pritchard-Jones et al. 
1993). Since these findings in the early nineties several other regions have also 
been found to express Wtl, In 1998 with the use of a LacZ reporter gene inserted 
into exon 1 of the Wtl locus using yeast artificial chromosomes (YACs), Wtl was 
found to be expressed in the septum transversum, which is the primitive diaphragm 
(Moore, Schedl et al. 1998). Although the expression of Wtl has been investigated 
in depth, these analyses could not elucidate its specific function within these 
tissues. Further investigations were needed in order to determine the role for Wtl 
in development.
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The function of Wtl in the developing embryo
In order to determine a function for Wtl Kreidberg and colleagues in 1993 used a 
targeted mutation of the Wtl gene. Their targeting strategy deleted the first exon of 
Wtl and an upstream sequence of 0.5kb. Mice heterozygous for the mutated Wtl 
did not appear to have any developmental problems. At the age of 10 months the 
mice had not developed any tumours. In contrast, the death of homozygous mutant 
mice occurred between El3 and El 5. No kidney developed in the mutants due to 
induction failure of the metanephric mesenchyme, and there was no ureteric bud 
(Figure 1.7). The conclusion drawn from the resulting lack of kidneys was that Wtl 
must play a critical role in kidney development from an early stage. However, they 
also noted that kidney agenesis was not a valid reason for embryonic lethality at 
El3 to El5. This lead to investigations into finding other tissues affected in the 
mutant. There was immense oedema throughout the embryo from El2 due to 
haemodynamic problems. Examination of the mutant heart found it to be 
significantly smaller than that of wild-type embryo. Mutants had a smaller left 
ventricle, which was dilated and had a very thin muscular' wall. The functional 
quality of the mutant heart was not tested but from its structure, oedema and 
circulatory problems, it was assumed that death occurred due to the abnormal 
development of the heart. Other phenotypes noted in mutants were abnormal 
formation of the septum transversum, which lead to the thoracic contents 
herniating into the abdominal cavity, a reduction in size of the lungs as well as 
incomplete development of the mesothelial lining, the pleura (Kreidberg, Sariola et 
al. 1993). As mesothelial cells have been reported to undergo EMT and renal tissue 
undergoes MET during development, it was put forward that Wtl plays a role in
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these processes (Armstrong, Pritchard-Jones et al. 1993; Kreidberg, Sariola et ah 
1993).
Wtl as a tumour suppressor gene and a potential oncogene
Wtl was first identified as a tumour suppressor gene due to mutations detected in 
the Wtl gene that lead to an inactive form of Wtl protein (Coppes, Campbell et al. 
1993). Mutations in the Wtl gene account for 10% of sporadic Wilms’ tumours 
(Park, Schalling et al. 1993). Wilms’ tumours correspond to the Knudson two-hit 
statistical model which states that two mutational events must happen in order for 
tumorigenesis to occm* (Knudson 1971). One mutation is inherited and the other 
occurs randomly in somatic cells. This model was first described after 
investigation into retinoblastoma, a malignancy of the eye (Knudson 1971). It was 
then found that Wilms’ tumour development follows the two-hit model (Knudson 
and Strong 1972). Wtl was, therefore, considered a tumour suppressor gene 
suppressing the transcription of genes by binding to DNA via the pro line/glutamine 
rich region of the Wtl protein (Figure 1.9) (Rauscher 1993; Hastie 1994) and 
promoting apoptosis and suppressing growth signals (Essafi and Hastie 2010). 
Over expression of Wtl in a Wilms’ tumour cell line (RM1) revealed tumour cell 
growth was suppressed in vitro (Haber, Park et al. 1993). This finding further 
indicated a role for Wtl in tumour suppression. However, a mutated version of Wtl 
where zinc finger 3 is missing was thought to be associated with a known 
oncogene (ElA) and so it was concluded that Wtl may also function as an 
oncogene causing the development of tumours (Haber, Timmers et al. 1992). Wtl 
expression has since been detected in several adult tumours such as breast (Loeb, 
Evron et al. 2001), colorectal (Koesters, Linnebacher et al. 2004) and leukemic
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(Algai-, Khromykh et al. 1996; Sugiyama 2005). Treatments for such tumours have 
shown inhibition of tumour growth when Wtl is knocked down with the use of 
Wtl antisense oligomers and Wtl-specific siRNA (Algai-, Khromykh et al. 1996; 
Sugiyama 2005; Tatsumi, Oji et al. 2008). Wtl has been shown to regulate 
oncogenes by activation as well as repression. Further work is needed in order to 
understand the process by which Wtl functions in activation and repression of 
tumorigenesis.
Wtl and MET/EMT
Wtl had long been hypothesised as having a function in the process of EMT and 
MET. Investigations were carried out in order in attempt to prove this. One such 
study employed an in vitro system where kidneys were removed from Ell mouse 
embryos and placed into culture. The kidney cultures were subjected to small 
interfering RNAs (siRNAs) in order to investigate Wtl function in nephron 
differentiation (Davies, Ladomery et al. 2004). SiRNA is a technique for 
‘ silencing ’ a particular gene by means of RNA interference (Elbashir, Harborth et 
al. 2001; Harborth, Elbashir et al. 2001). Knocking down Wtl in kidney cultures 
resulted in nephrogenic failure. Nephrogenesis relies on the process of MET, 
whereby metanephric mesenchymal cells are transformed into epithelial nephron 
precursors. Therefore they concluded that Wtl is required for the onset of MET in 
kidney development (Davies, Ladomery et al. 2004; Hohenstein and Hastie 2006).
Alternative splicing of the Wtl gene
Alternative splicing allows many different proteins to be generated from a single 
gene. This occurs by splicing together different parts of exons, creating different
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types of mRNA and therefore different protein isoforms are produced. There are 
several alternative splicing sites on the Wtl gene (Hammes, Guo et al. 2001). Two 
are characterised by the absence or presence of a number of amino acids at these 
specified sites (Figure 1.9). An alternative splicing domain can be found at exon 5. 
Exon 5 consists of 17 amino acids and is either present or missing to form two Wtl 
isoforms (Hohenstein and Hastie 2006). A second alternative splice site is found 
between exons 1 and 2 (Dallosso, Hancock et al. 2004). The testis were found to 
express a smaller Wtl transcript as well as the original transcript (Pritchard-Jones, 
Fleming et al. 1990). This finding led to further investigations aiming to locate 
more alternative splicing domains (Dallosso, Hancock et al. 2004). A truncated 
version of Wtl was found and was named AWT1, where alternative splicing was 
shown to take place at the N-terminal of Wtl and produced an alternative exon 1. 
The function of AWT1 is yet to be determined. However, AWT1 has been shown 
to be confined to the paternal allele (Dallosso, Hancock et al. 2004). There is also 
an alternative splicing domain which is characterised by the absence or presence of 
only three amino acids (lysine, threonine and serine) between the third and fourth 
zinc fingers at exon 9 (Schedl, Larin et al. 1993). This amino acid complex is 
referred to as KTS. There are two isoforms produced and these are Wtl +KTS and 
Wtl -KTS (Hohenstein and Hastie 2006).
Examples of roles for Wtl splice variants
The +KTS and -KTS isoforms of Wtl have been conserved in all vertebrates 
(Hastie 2001; Hohenstein and Hastie 2006) and have, therefore, been the subject of 
intense study. Gene targeting techniques have allowed the deletion of these 
specific isoforms in order to determine what role they play in development. Mouse
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mutants have been generated, which contain the Wtl +KTS or Wtl -KTS isoform 
exclusively (Hammes, Guo et al. 2001). Both mutants were found to die shortly 
after they were bom due to defects in the kidney, which included haemorrhaging of 
the kidney and an empty bladder indicting a deficiency in glomerular filtration 
(Hammes, Guo et al. 2001). Although the outcome of both was death in both the 
+KTS and -KTS Wtl isoform mutants, the phenotypes produced due to the 
deletion of each of the isoforms was distinct, which suggested they each have a 
distinct function. +KTS mutants revealed massively reduced levels of the Y- 
chromosome specific sex detennination gene Sry and an absence of foot-like 
processes found in the podocytes of the kidney. These findings indicated the +KTS 
isoform of Wtl was essential for Sry expression, which is required for the initiation 
of testis development in the male (Gubbay, Collignon et al. 1990; Sinclair, Berta et 
al. 1990; Hammes, Guo et al. 2001). The findings also suggested an important role 
for the +KTS isoform in the development and maintenance of podocyte structure 
(Hammes, Guo et al. 2001). The -KTS mutants demonstrated a decrease in size of 
the kidneys and the gonads. Analysis of this phenotype revealed an increase in 
apoptosis in cells at the urogenital ridge, which resulted in the failure of proper 
development of the kidney and gonad. These findings suggested that the -KTS 
isoform of Wtl is crucial for the survival of urogenital progenitors (Hammes, Guo 
et al. 2001).
Wtl in sex determination
Sox9 is a member of the Sry-HMG-box group of transcription factors, along with 
Sox 10 (Hong and Saint-Jeannet 2005). SoxlO is a NCC marker for developing 
ENS precursors and Sox9 is also expressed in the neural crest (Hong and Saint-
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Jeannet 2005). SoxlO functions in the neural crest-derived ENS and melanocytes 
(Hong and Saint-Jeannet 2005), This was shown using SoxlO mutant mice, which 
had aganglionosis of the gastrointestinal tract (Herbarth, Pingault et al. 1998; 
Southard-Smith, Kos et al. 1998). Sox9 does not function in the developing ENS 
but has been shown to have an important role in neural crest-derived chondrocytes, 
which go on to from parts of the skeletal system (Kent, Wheatley et al. 1996). 
Sox9 mutants show skeletal malformations and sex reversal. This is analogous to 
the human condition campomelic dyplasia, which occurs due to a mutation at the 
Sox9 locus (Foster, Dominguez-Steglich et al. 1994; Wagner, Wirth et al. 1994; 
Hong and Saint-Jeannet 2005). This suggested that Sox9, like Sry, plays a role in 
sex determination and bone differentiation.
Sex determination arises via the testis-determining gene, which is specific to the Y- 
chromosome. It was discovered during genetic analysis of patients presenting with 
sex reversal. This testis- determining gene was tenned the Sry gene (Gubbay, 
Collignon et al. 1990; Sinclair, Berta et al. 1990). The Sry gene has been found to 
be critical for sex determination as expression of Sry was shown to lead to testis 
development even in XX genotypes (females) (Koopman, Gubbay et al. 1991). 
Sox9 mRNA and protein were shown to be expressed in the gonad of the 
developing mouse (Kent, Wheatley et al. 1996). Sox9 was found to be testis- 
specific and up-regulated in the developing gonads of the mouse a short time after 
the expression of the Sry gene had been activated (Kanai, Hiramatsu et al. 2005). 
These studies suggested Sox9 played a role in the sex detennination of the male 
and not the female phenotype, and it was thought that Sox9 could be activated by 
Sry up-regulation (Kent, Wheatley et al. 1996). A Sox9 conditional null mouse was
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generated employing the Flox/Cre-LoxP system (Akiyama, Chaboissier et al. 2002; 
Kist, Schrewe et al. 2002). The Sox9 null mutant was found to develop gonads. 
However, embryonic death occurred around El 1.5 due to defects in the 
development of the cardiovascular system (Akiyama, Chaboissier et al. 2002; Kist, 
Schrewe et al. 2002; Kobayashi, Chang et al. 2005). Due to the early lethality of 
the Sox9 null mutant embryos at El 1.5 the genital ridge was dissected and cultured 
in an in vitro system for 2-3 days to attempt to determine how they developed. This 
investigation revealed that testicular cords did not develop in Sox9 null mutants. It 
was also found that markers for Sertoli cells, such as Amh (mtillaiian inhibiting 
substance) were not expressed (Kobayashi, Chang et al. 2005). It was concluded 
from the examination of in vitro cultures that Sox9 is vital for the development of 
the testis (Kobayashi, Chang et al. 2005).
It has also been shown that Wtl is related to sex determination and is involved in 
modulation of Amh (Nachtigal, Hirokawa et al. 1998). Wtl is well documented as 
being expressed in the developing gonad and sertoli cells of the adult testis 
(Armstrong, Pritchard-Jones et al. 1993; Kreidberg, Sariola et al. 1993). An 
investigation was carried out to determine if Wtl had an effect on Sox9 expression 
and therefore sex determination. This was achieved by ablating Wtl in Sertoli 
cells, in the adult, by using a Wtl conditional knockout mouse. The Sertoli cell 
specific knockout was generated by crossing a Wtlflox mouse, which contained a 
Wtl conditional knockout allele, with an Amh-Cro mouse. The results of these 
studies revealed Sox9 was down-regulated in the mutant sertoli cells. These 
findings suggested Wtl is required for maintenance of Sox9 expression in sertoli 
cells (Gao, Maiti et al. 2006). A conserved region 5’ of Sox9 has been found,
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including a putative Wtl-binding site (Bagheri-Fam, Ferraz et al. 2001). This 
finding is in support of the idea that Wtl has a direct involvement in Sox9 
expression (Bagheri-Fam, Ferraz et al. 2001; Gao, Maiti et al. 2006).
Lineage tracing of Wtl
The Wtl-CreRosa26 reporter mouse was the product of mating Wtl-Cre transgenic 
mice with the Rosa26 reporter mouse strain (Wilm, Ipenberg et al. 2005) (Figure 
1.10). This involved the Cre-LoxP system, which is a way of manipulating DNA 
and developing mouse strains when looking at gene function or ablation 
(Rajewsky, Gu et al. 1996; Soriano 1999). A Cre-recombinase enzyme recognises 
the 34bp sequence of LoxP (Hoess, Ziese et al. 1982; Argos, Tandy et al. 1986; 
Rajewsky, Gu et al. 1996). By using LoxP sites to flank a sequence of DNA the 
Cre-recombinase can excise that particular sequence. This means genes can be 
replaced or deleted, or signal sequences removed in order to activate gene 
expression (Rajewsky, Gu et al. 1996). In the Wtl-Cre mouse line a Cre- 
recombinase was placed under the control of the human WT1 promoter. This was 
achieved by using yeast artificial chromosomes (YACs) because they are easy to 
manipulate (Schedl, Larin et al. 1993; Moore, Schedl et al. 1998; Wilm, Ipenberg 
et al. 2005). The Rosa26 reporter mouse strain was developed in order to examine 
Cre-expression. A LacZ gene was placed under the control of the Rosa26 
promoter, along with LoxP sites, which flanked a STOP cassette. Rosa26 is 
ubiquitously expressed (Soriano 1999). When the two mouse strains, Wtl-Cre and 
Rosa26R, were crossed the Cre-recombinase would excise the STOP cassette. 
Following recombination, LacZ would be expressed in any cells that were either 
expressing Wtl or were derived from Wtl-expressing cells. Therefore, the fate of
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Wtl-expressing cells could be followed and when stained for LacZ these cells 
could be visualised with a blue precipitate (X-Gal staining) (Figure 1.8). LacZ 
staining, using this system has been shown in many tissues and structures where 
Wtl has been reported to be expressed or play a role in their development. Such 
structures include mesothelial cells and the vascular smooth muscle component of 
heart, lung and gut musculature (Wilm, Ipenberg et al. 2005; Que, Wilm et al. 
2008). LacZ staining has also been demonstrated in the adrenal gland, epicardium, 
diaphragm, and kidney (Moore, Schedl et al. 1998; Moore, Mclnnes et al. 1999). 
As well as the aforementioned tissues LacZ staining was also detected in cells in 
the region of the ENS of the adult mouse gut (Figure 1.8) (Wilm, Ipenberg et al. 
2005) In order to confirm LacZ staining was present in the ENS 
immunofluorescence co-staining was carried out in newborn Wtl-CreRosa26R 
mice for the pan-neuronal marker Hu and P-Galactosidase (Figure 1.11). The 
results revealed P-Galactosidase and Hu co-localised in around half of the enteric 
neurons (Figure 1.11) (Wilm, unpublished).
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1.4 Aims of the project
Therefore, this project aimed to establish the time-point at which Wtl was 
expressed in the developing ENS, since LacZ expression in the adult ENS and [3- 
Galactosidase expression in the newborn ENS of the Wtl-Cre mouse line had been 
previously and unexpectedly observed (Figure 1.8 and Figure 1.11) (Wilm, 
Ipenberg et al. 2005). However extensive investigation into the expression pattern 
of Wtl has shown that it is not expressed in the ENS of the post-natal mouse as 
expression becomes highly restricted and is only found in the podocytes of the 
kidney glomerulus and the mesothelium (Rivera and Haber 2005); (Wilm, 
Ipenberg et al. 2005). Thus I aim to systematically examine embryonic 
development of the ENS employing immunohistochemical and in situ 
hybridisation techniques in order to determine when Wtl was expressed to explain 
the results of the lineage tracing experiments.
The establishment of this time point is essential for the experiments described in 
the second part of this thesis designed to investigate the hypothesis that Wtl has a 
function(s) in the developing ENS. I therefore aim to characterise the behaviour of 
vagal level NCCs in vitro. I also aim to set up a siRNA gene knock down system in 
kidney stem cells, which once optimised in the future could be adapted for use on 
NCCs. This will be important in future projects aiming to elucidate the function for 
Wtl in NCCs,
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The questions that need addressing are:
• Is Wtl expressed in the developing ENS?
• At what time-point is Wtl expressed in the developing ENS?
• How do NCCs behave in vitro?
• With the use of siRNA can Wtl be knocked down in kidney stem cells for 
eventual use on NCCs?
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Figure 1.1 Neural crest development in the mouse
Figure adapted from Jessen and Mirsky (2005) showing the process of neurulation, 
which consists of the generation of the neural tube (primitive brain and spinal cord, 
blue) and the neural crest (yellow) (Jessen and Mirsky 2005). Neurulation 
commences when the neural plate, derived from ectoderm, begins to invaginate to 
form the neural groove (Shum and Copp 1996). The neural crest forms at the peak 
of the neural folds, between the neural and surface ectoderm (green). As the neural 
folds unite to produce the hollow neural tube, which is a continuous process 
between the stages of E8.5 and El0.5 in the mouse, the neural tube detaches from 
the surface ectoderm to produce two distinct structures. During this time cells of 
the neural crest (NCCs) undergo EMT (Sauka-Spengler and Bronner-Fraser 2008) 
in order to detach from their epithelial environment of the neural tube, and migrate 
throughout the embryo.
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Figure 1.2 Vagal and sacral NCC contribution to the ENS
This figure shows a schematic representation of ENS development in the mouse 
adapted from Heanue and Pachnis 2007 (Heanue and Pachnis 2007). Vagal NCCs 
are shown in red and account for the majority of the total cell population of the 
developing ENS. Sacral NCCs are shown in yellow at the caudal end of the 
embryo. There is also a small contribution of NCCs from the trunk level neural 
crest (blue).
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Figure 1.3 Regional differences in neural crest-derived tissues
This figure was adapted from (Le Douarin 2004). It shows the varying tissues 
which are neural crest-derived in the chick, and the regions of neural crest which 
contribute to each tissue. Overlap between regions is shown. Mesectoderm (green) 
is restricted to the head region between prosencephalon and somite (s) 4 
(rhombencephalon). Pigment cells (melanocytes, grey) are derived from all levels 
of the neural crest. Parasympathetic ganglia region (yellow) is confined to 
mesencephalon. Enteric ganglia (orange) are derived from neural crest in the 
region of somites 1-7. Sensory ganglia (blue) are essentially formed from all 
regions of the neural crest. Sympathetic ganglia (red) are derived from the neural 
crest caudal to somite 4. Endocrine cells (lilac) are formed from neural crest at 
somites 2-4 and 18-24.
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Figure 1.4 Development of the ENS
Figure adapted from Young and Newgreen, 2001 showing the colonisation of 
vagal NCCs in the mouse embryonic gut between El0.5 and El4.5, during ENS 
development (Young and Newgreen 2001). The vagal NCCs migrate in a rostro- 
caudal manner. Following the migration the neural tube at E8.5 and entry into the 
foregut at E9.5 (Young, Hearn et al. 2000) the NCCs reach the midgut by E10.5 
(A). By El 1.5 the caecum (proximal colon) has been colonised (B). Between 
El2.5 and E14.5 the NCCs begin to colonise the hindgut (C) and are found 
throughout the entire gastrointestinal tract (D).
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Figure 1.5 Enteric aganglionosis in various knock-out mice
This figure has been adapted from (Young and Newgreen 2001). It shows the 
varying degrees of enteric aganglionosis in a number of different knock-out mice. 
Image A shows total aganglionosis in the Sox 10 and Phox2b knock-out mice. 
Image B shows aganglionosis is confined to the oesophageal region in the Mashl 
knock-out mouse. The Gdnf, Ret and Gfral knock-out mice show aganglionosis 
distal to the stomach with a small portion of the most distal bowel retaining enteric 
ganglia (*, C). Image D shows aganglionosis in the caudal pail of the gut, the large 
intestine, in Et-3, Et(B) receptor and Ece-1 knock-out mice. Gdnf, glial derived 
neurotrophic factor. Et-3, endothelin-3. Et(B) receptor, endothelin B receptor. Ece- 
1, endothelin converting enzyme-1.
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Figure 1.6 EMT and MET at gastrulation
This figure was adapted from (Hugo, Ackland et al. 2007). It shows the earliest 
occurrence of EMT and MET during embryonic development, during gastrulation. 
A subset of cells from the epiblast (primitive ectoderm) undergoes EMT to 
produce motile mesenchymal cells. These cells form the third germ layer, the 
mesoderm, which lies between the ectoderm and the endoderm (hypoblast prior to 
gastrulation). ECM, extra-cellular matrix.
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Figure 1.7 Kidney development
Figure adapted from Rivera, 2005 and Dressier, 2006 showing the process of 
nephrogenesis. Wtl-expressing cells are shown in green throughout. At E9.5 the 
intennediate mesoderm (IM) can be identified in the developing mouse embryo 
and expresses Wtl (green). The most caudal end of the IM is the metanephric 
mesenchyme (MM), which lies next to the Wolffian duct (A). The process of 
induction begins at El0.5 when the ureteric bud (UB) branches from the Wolffian 
duct and invades the MM (B). The action of UB invasion causes the condensation 
of the MM around the tip of the UB at El 1.5 (C). The MM undergoes MET and 
forms epithelial renal vesicles at El2.5, meanwhile further branching of the UB 
continues (D). At El3.5 tubules (proximal and distal) begin to form and the renal 
vesicle becomes more complex, producing the S-shaped body. Between El4.5 and 
El6.5 the nephron matures and endothelial cells invade to form the glomerulus. 
Wtl expression becomes restricted to the podocytes of the glomerulus (Rivera and 
Haber 2005; Dressier 2006).
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Figure 1.8 Wtl-derived cells in the ENS
Figure adapted from Wilm, 2005 showing whole-mount LacZ staining of an adult 
mouse intestine (A and B). Image B is a high magnification image of the boxed 
area in image A. The blue arrowheads indicate Wtl-derived serosal mesothelial 
cells which contribute to the smooth muscle component of the intestinal 
vasculature (B) (Wilm, Ipenberg et al. 2005). Black arrows reveal LacZ staining 
localised in the adult mouse ENS (B). Image C shows a schematic diagram of the 
myenteric plexus (adapted from (Furness 2006). LacZ staining follows a similar 
pattern to that seen in the diagram (B and C).
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Figure 1.9 Wtl gene and protein
Figure adapted from (Vize, Woolf et al. 2003) showing a schematic diagram of the 
Wtl gene consisting of 10 exons (A). AWT1 consisting of an alternative exonl is 
shown in B. AWT1 encodes a shorter protein than the original Wtl transcript. 
Green box represents the alternative exon 1 (Alt 1). Wtl encodes a protein with a 
proline/glutamine rich domain and four zinc fingers (C). Blue boxes represent two 
alternative slice sites. The first at exon 5 and the second at the 3’ end of exon 9, 
characterised by the presence or absence of three amino acids, KTS (leucine, 
threonine, serine).
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Figure 1.10 Lineage tracing of Wtl-derived cells
The Wti-Cre mouse (A) carries a Cre recombinase (green) under the control of the 
human Wti promoter (red). This was crossed with the Rosa26 reporter mouse line 
(B), which has a LacZ cassette (dark blue) under the control of the ubiquitously 
expressed Rosa26 promoter (light blue). A stop cassette flanked by LoxP sites 
(green triangles) prevents LacZ expression. The Wti-expressing cells within the 
progeny (C) of this Wti-Cre and Rosa26R crossing contain active Cre 
recombinase. The Cre acts on the LoxP sites and the stop cassette is excised 
causing expression of (3-Galactosidase. Due to ubiquitous expression of Rosa26 
any cell expressing Wti or Wtl-derived cell will express LacZ and lineage could 
be traced by visualising a blue precipitate when X-Gal staining or 
immunofluorescence for (3-Galactosidase is performed.
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Figure 1.11 p-Gal expression in enteric neurons
Frozen sections taken from newborn mouse intestine showing immunofluorescence 
co-stained for p-Gal (Wtl-derived cells, A, green) and pan-neuronal marker Hu 
(enteric neurons, B, red). Image C is a composite showing co-localisation of Hu in 
around half of enteric neurons (C, yellow arrows). The nuclear stain DAPI is 
shown in blue (A-C). L, intestinal lumen.
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Table 1.1 Adapted from Young and Newgreen, 2001. This table shows the molecules 
and genes expressed by NCCs during ENS development. Expression shown in orange
(e.g. Yes).
Marker Function Species
Expression 
in NCCs 
prior to 
entry to 
gut
Expression 
in NCCs 
within the 
gut
References if 
differ from 
Young and 
Newgreen,
2001
Transgenes
DBH-lacZ LacZ expression 
driven by the 
promoter of the 
catecholamine 
synthetic 
enzyme, DBH
Mouse No Yes
CCK-LacZ LacZ expression 
driven be the 
promoter of 
regulatory 
peptide, CCK
Mouse Yes Yes
PO-Cre LacZ expression 
in cells
expressing the
P0 glycoprotein 
(cell adhesion 
molecule)
Mouse Yes Yes
Receptors for neurotrophic factors
Ret Receptor 
tyrosine kinase; 
forms part of the 
receptor 
complex for 
GDNF.
Downstream of 
Hoxb5
Mouse,
chick,
rat
Yes Yes (Lui, Cheng et al. 
2008)
GFRal Forms part of 
the receptor 
complex for 
GDNF, along 
with Ret
Mouse,
rat,
chick,
zebrafish
Reports
suggest
not
Yes (Schiltz, Benjamin 
et al. 1999;
Taraviras, Marcos- 
Gutierrez et al.
1999; Lucini,
Facello et al. 2010)
ErbB3 Receptor 
tyrosine kinase; 
receptor for 
neuroregulin-1
Mouse Yes Yes
p75mK Low-affinity
neurotrophin
receptor
Rat,
Mouse
Yes Yes
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TrkC Receptor for
NT-3
Rat,
mouse
Reports 
suggest not
Yes (Chalazonitis
2004; Chalazonitis, 
D'Autreaux et al. 
2004; Levanti, 
Esteban et al.
2009; Bartkowska, 
Turlejski et al.
2010)
ET-B receptor Receptor for 
Endothelin 3
Mouse,
human,
chick,
quail
Yes Yes
CNTFRa a component of 
neuropoietic 
cytokine 
receptor
Rat Reports
suggest
not
Yes (Masu, Wolf et al.
1993; Rhee and
Yang 2010)
Gpl30 and 
LIFRp
p components of 
neuropoietic 
cytokine 
receptor
Rat Reports
suggest
not
Yes (Masu, Wolf et al.
1993; Rhee and
Yang 2010)
Neurotransmitter-related molecules
5-HT
transporter 
and receptor
Transporter and 
receptor for 
serotonin
Rat,
mouse
Reports
suggest
not
Yes (Vitalis, Alvarez et 
al. 2003; Li, Caron 
et al. 2010)
Tyrosine
Hydroxylase
Catecholamine
synthetic
enzyme
Mouse,
rat
Yes Yes
Transcription factors
MASH1 Mammalian 
homologue of 
Drosophila 
proneural genes
Mouse,
rat
No Yes (Okamura and
Saga 2008)
Phox2a Involved in 
cascade 
involving Ret 
and MASH1
Mouse No Yes
Phox2b Essential for 
expression of
Ret and TH
Mouse Yes Yes
Sox 10 Activator of 
regulatory 
cascade in ENS 
and melanocyte 
development. 
Interacts with
Pax 3
Mouse Yes Yes (Hong and Saint- 
Jeannet 2005; 
Betancur, Bronner- 
Fraser et al. 2010; 
Nelms, Pfaltzgraff 
et al. 2011;
Sommer 2011)
Foxd3 Maintains neural 
crest
progenitors. 
Interacts with 
Pax3 in cardiac 
NC
Mouse Yes Yes (Teng, Mundell et 
al. 2008; Nelms, 
Pfaltzgraff et al. 
2011)
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cHoxllL2 Activation 
important 
pathway in T 
leukemogenesis. 
Neurons
Chick,
zebrafish
No Yes (Andermann and 
Weinberg 2001; 
Bernard, Busson- 
LeConiat et al.
2001)
HoxllLl Knockout is a 
mouse model for 
intestinal 
neuronal 
dysplasia
Mouse No Yes (Puig, Champeval 
et al. 2009)
HoxB5 Regulates 
angiogenesis via 
activation of 
flkl. Ret is a 
downstream 
target
Mouse Yes Yes (Wu, Moser et al. 
2003; Winnik, 
Klinkert et al.
2009)
HAND2 Transcriptional 
regulator. Binds 
to Ebox 
proteins.
Activates nanog
Mouse,
chick
No Yes (Dai and Cserjesi 
2002; Hashimoto, 
Myojin et al. 2009)
Miscellaneous proteins
Neurofilament Cyto skeleton 
component of 
neurons
Chick,
mouse,
rat
No Yes
N-cadherin Calcium-
dependent
adhesion
molecule
Mouse Yes Yes (Gaminill and 
Roffers-Agarwal 
2010; Kulesa and 
Gammiil 2010)
Nestin Intermediate 
filament protein
Rat,
mouse
Yes Yes (Kawaguchi,
Miyata et al. 2001; 
Wiese, Rolletschek 
et al. 2004)
4E9R NC-specific 
intermediate 
filament, related 
to vimentin
Mouse Yes Yes
E/C8 Antibody to
Avian-specific,
neurofilament-
associated
protein
Chick,
quail
Yes Yes
HNK-1 and 
NC-1
Monoclonal 
antibodies that 
recognise the 
carbohydrate 
epitope of a 
fanrily of 
glycoproteins
Chick, 
quail, 
rat, dog, 
Pig, 
human
Yes Yes
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Chapter 2
Materials and methods
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2.1 Animals
Wild-type CD-I® mice were purchased from Charles River Laboratories 
International, Inc. Time-mated females were killed in accordance to Schedule 1 of 
the Animals (Scientific Procedures) Act 1986. Embryos were obtained following 
Home office regulations and decapitation was performed on any embryos from half 
way through gestation onwards.
2.2 Detection of protein using immunostaining techniques
Preparation for immunofluorescence and generation of frozen sections
Mouse embryos at embryonic stages (E) between E7.5 and El6.5 were dissected 
from maternal and extra-embryonic tissues. The embryos were incubated at 4°C in 
4% paraformaldehyde (PFA) for fixation (Table 2.1). The fixed embryos were 
washed 3 times for 5 minutes in phosphate buffered saline (PBS) to ensure no PFA 
was remaining. They were then incubated overnight at 4°C in 20% sucrose 
solution. This was done to protect the integrity of tissues during the freezing 
process. Individual embryos were then embedded in Shandon cryomatrix 
embedding compound (Thermo Scientific) and frozen using solid carbon dioxide 
(CO2) and 2-propanol. The frozen embryos were wrapped in foil and were stored at 
-80°C until ready for sectioning. Embryos were sectioned using a cryostat at -20°C 
using Superfrost plus slides (Thermo Scientific), placing between 4 and 12 sections 
per slide depending on the embryonic stage.
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Immimohistochemistry on frozen sections
Frozen sections were removed from -80°C and allowed to thaw at room 
temperature for 5-10 minutes. Slides were kept in humidified conditions to prevent 
the tissue from dying out. Once thawed, they were washed 3 times in PBS to bring 
them back into a physiological state. The tissue was then permeabilized with 
0.25% Triton solution (v/v) (Fluka) for 10 minutes at room temperature before 
three more 5 minute washes in PBS. Blocking was perfonned for 1 hour at room 
temperature using 2% bovine serum albumin (BSA). During this blocking step 
primary antibodies were diluted to their working concentration in 2% BSA (w/v) 
(Table 2.1). The sections were incubated in primary antibody overnight at 4°C. 
Negative controls were incubated in 2% BSA without primary antibody. The next 
day the primary antibody was washed off using three 5 minute PBS wash steps. 
During this time secondary antibodies plus DAPI were diluted (Table 2.1). 
Sections were incubated with secondary antibody in the dark at room temperature 
for 1 hour. This was followed by another three 5 minute PBS washes to ensure that 
no antibody was left over. Slides were then mounted with anti-fade mounting 
media (Electron Microscopy Sciences) and glass cover-slips. They were left to dry 
for 10 minutes and sealed using clear* nail polish. For prolonged storage the slides 
were kept at 4°C.
Neural tube explants were cultured at 37°C in DMEM (Sigma) plus 5% NCS and 
5% horse serum (Sigma). They were plated onto cover-slips which had been coated 
with a 0.5% gelatine solution and placed into 24 well plates. They were fixed for 
10 minutes at room temperature in 4% PFA and stained with antibodies as 
described above.
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Kidney stem cells (KSC) were seeded on 8-well chamber slides in high glucose 
DMEM (Invitrogen) supplemented with 2mM glutamine and 10% PCS. The cells 
were fixed for 10 minutes at room temperature in 4% PFA and were stained with 
antibodies as described above.
Immuno-staining on whole-mount mouse embryos
E8.5 mouse embryos were fixed in 4% PFA (w/v) at 4°C for 45 minutes. They 
were washed three times in PBS for 5 minutes and dehydrated through a series of 
methanol concentrations (25%-75% (v/v) each for 30 minutes) into 100% 
methanol. They were then stored at -20°C until ready for use. Embryos were 
bleached in 6% hydrogen peroxide (H2O2) diluted in methanol for 1 hour at room 
temperature. They were then rehydrated through the methanol series (75%-25% for 
30 minutes) into PBS-0.25% Triton (PBST) at room temperature, rocking. 
Embryos were permeabilized with three 20 minute washes in PBS-1% Triton 
(PBST) at room temperature, rocking. Blocking was followed by incubating 
embryos in PBSMT (PBST + 2% skimmed milk) for 1 hour’ at room temperature, 
rocking. They were then incubated with primary antibody diluted in PBSMT 
(Table 2.1) overnight at 4°C, rocking. On day 2 three brief washes in PBSMT were 
followed by five 1 hour washes with PBSMT at 4°C, rocking. They were then 
blocked once again in PBSMT for 1 hour at 4°C. Secondary antibody coupled to 
horse radish peroxidise (HRP) was diluted in PBSMT and the embryos were 
incubated overnight at 4°C, rocking (Table 2.1). The third day started with three 
brief washes in PBSMT. They were then washed at 4°C for 1 horn- in PBSMT, 
rocking. Samples were then washed with PBST for 20 minutes. After this the 
colour reaction was canied out as follows: the embryos were washed for 20-30
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minutes in PBS (no triton) containing 0.5% nickel chloride (NiCh), 0.3mg/ml 
DAB (Sigma). H2O2 was added to reach a final concentration of 0.01% and they 
were incubated for 5-10 minutes whilst colour developed. After this they were 
washed with PBST and fixed overnight in 4% PFA at 4°C.
2.3 Molecular biology
Wtl full-length cDNA probe was obtained from the Kreidberg lab, Children’s 
Hospital Boston. In order to recover the plasmid after transportation the sample 
was added to lOmM Tris at pH7.6. This was followed by brief vortexing and was 
allowed to hydrate for 10 minutes. The solution was centrifuged briefly and the 
supernatant was then prepared for the transformation of competent bacteria.
Heat shock transformation of bacteria with plasmid DNA
5 pi of plasmid DNA was added to 200pl aliquots of competent bacteria and mixed 
gently. This was left on ice for 30 minutes. During this time the water bath was set 
to 42°C. Following incubation on ice the cells were placed into the water bath for 
90 seconds. After heat shock treatment the cells were returned to ice and then 
transferred into BOOpl Luria broth (LB) trans and placed into the bacterial shaker at 
37°C for 1 hour. LB broth plates were incubated at 37°C whilst cells were in the 
shaker in order to warm. 50 pi of the transformed bacteria was plated onto LB agar 
plates containing ampicillin using a pipette and Bunsen burner. The plates were 
then incubated at 37°C overnight.
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Plasmid selection and mini-culture set up
LB broth plates were removed from the incubator the next morning. A 5ml LB plus 
ampicillin (1:1000) solution was set up for each transformation. 1 colony per 
transformation was chosen and cells from this colony were transferred into the 
LB/ampicillin culture. This was then placed into the shaker at 37°C over night.
Generation of glycerol stocks
Glycerol stocks were produced from mini-cultures for future use. 1.5ml of bacterial 
transformation was added to 0.5ml 60% glycerol. The solution was mixed 
completely by vortexing and the solution was stored at -80°C.
Preparation of plasmid DNA
In order to confirm the insert within the plasmid a mini plasmid preparation was 
carried out using the TENS method. 1.5ml from the mini-culture was placed into a 
microfuge tube and span in the centrifuge for 1 minute at full speed. The 
supernatant was discarded leaving only a small volume (around 50 pi) with the 
pellet. The pellet was resuspended in the remaining LB broth by vortexing. 300pi 
of TENS buffer was added in order to lyse the cells. The samples were placed on 
ice for 5 minutes and inverted occasionally to ensure they remained mixed. Once 
the sample had incubated on ice and became milky 150pl 3M NaAc (pH5.0) was 
added followed immediately by inverting. The high salt content and acidic pH 
neutralised the sample and they became clear with a white precipitate. The white 
precipitate contained the DNA and protein and the plasmids, which re-annealed 
remained in the solution. The samples were then centrifuged for 5 minutes at 
maximum speed. The supernatant was collected and transferred to a separate tube
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containing 900|il of ethanol. This was mixed and incubated at -20°C for 30 
minutes in order to gain maximal plasmid precipitation. The samples were then 
centrifuged for 5 minutes at full speed, the supernatant was decanted and 700pi of 
70% ethanol was added twice to wash out any remaining salt. This was centrifuged 
briefly leaving behind an opaque pellet. The supernatant was removed 
immediately. The pellet was allowed to dry by evaporation and once it was 
completely dry 30pi TE buffer was added. The pellet was resuspended by 
vortexing. The preparation was stored at 4°C ready for restriction enzyme 
digestion.
Restriction enzyme digestion of plasmid DNA
Notl (Biolabs, Inc.) and £cc>RI (Fermentas) restriction enzymes were used on DNA 
from mini plasmid preparations in order to make sure that the insert was present 
and the correct size. Restriction digests were set up containing 0.5pi Notl 
restriction enzyme, 0.5pl EcoRl restriction enzyme, ipl lOx buffer, 5.5pl H2O and 
3 pi of plasmid DNA. They were incubated for 2 hours at 37°C and analysed on a 
1% agarose gel. In order to produce larger quantities for generating sense and 
antisense probes for use with in situ hybridisation experiments transformed 
bacteria was grown overnight in 100ml LB/ampicillin (lOOpg/ml). The plasmid 
was prepared using Qiagen maxi plasmid preparation kit.
Linearising plasmid for transcription
20pg of plasmid containing the full length cDNA mouse Wtl insert of 1.4kb was 
linearised using the AM (antisense probe) and AcoRI (sense probe) restriction 
enzymes. This was achieved by mixing 20pl of DNA, lOpl of lOx buffer, 5pi
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restriction enzyme and 35|ri H2O was added to a final volume of lOOfri. This mix 
was incubated at 37°C for 2 hours. At this point 5pi was removed and run on an 
agarose gel to control for complete linearization. After linearization a further 100pi 
of H2O was added to the mixture and Phenol-Chloroform extraction was 
performed. 200pl Phenol was added and mixed by vortexing. This was then 
centrifuged for 2 minutes at 1300rpm. The upper phase was collected and 
transferred to a fresh tube. This was repeated once, and the upper phase was 
collected and transferred to a fresh tube. To this 200pi of Chloroform- 
Isoamylalcohol (Sigma) was added, mixed by vortexing and centrifuged for 2 
minutes at 1300rpm. The watery phase was aspirated and added to 20pl sodium 
acetate (NaAc) (1:10 dilution). Three volumes of 100% ethanol were added 
(600pl). This mix was incubated at -20°C for 30 minutes. After incubation the 
mixture was centrifuged at 4°C for 20 minutes. The pellet was washed in 70% 
ethanol and allowed to dry. It was then resuspended in diethylpyrocarbonate 
(DEPC)-treated H2O and stored at -20°C until transcription.
Xu vitro transcription of a Wtl in situ probe
In order to prepare the Wtl probe for in situ hybridisation Ipg of linearised 
template plasmid was added to 20pl total volume with final concentrations of lx 
transcription buffer, lx DIG-RNA labelling mix (Roche), lx DTT, lU/pl RNAse 
inhibitor and lU/pl RNA-polymerase (T3 antisense, T7 sense - Roche), diluted in 
RNAse free H2O. This mixture was incubated at 37°C for 2 hours. The following 
was then added to make the total volume up to 50 pi: lx DNAse buffer (RNAse 
free) (Roche) and 2U DNAse (RNAse free) (Roche), diluted in RNAse free H2O. 
This solution was incubated at 37°C for 30 minutes. Ipl of this transcription mix
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was removed and added to 20fal of 50% Formamide, TE and loading buffer for gel 
estimation. The probe was then purified using Sephadex Columns (GE 
Healthcare). A further Ipl was taken out and added to the Formamide buffer. This 
was loaded along with the pre-purification mix onto a 1.5% agarose gel. 2pl of 
RNAse inhibitor was added to the labelled probe for prolonged storage.
2.4 Detection of mRNA using in situ hybridisation
Whole mount in situ hybridisation
All solutions for RNA work were treated with DEPC or derived from DEPC- 
treated stock solutions. All glass ware was baked at 180°C for 2 hour's prior to use. 
Only filter pipette tips and pipettes were used. A 4% PFA solution was made up 
using DEPC-treated H2O and PBS. This was mixed in a glass beaker for RNA work 
that had been baked for 2 hour's at 180°C, This was sterile filtered and stored at 
4°C for up to 2 weeks. Mouse embryos between E7.5 and El0.5 were dissected 
from maternal and extra-embryonic tissues. Embryos were placed in 4% PFA at 
4°C, rocking gently for fixation (Table 2.2). After fixation the embryos were 
washed three times in PBT (PBS + 0.1% Tween-20) for 10 minutes each. They 
were then dehydrated through a methanol series (25%-100% meOH/PBT) for 30 
minutes each at 4°C with two washes in 100%. They can be stored in this way at - 
20°C. To continue the procedure a 4:1 solution of methanol and 37% H2O2 was 
prepared and the embryos were bleached at room temperature for 1 hour, rocking. 
They were then rehydrated back through the methanol series (75%-25%) for 30 
minutes each, into PBT at room temperature, rocking. The rehydrated embryos 
were then washed three times for 10 minutes in PBT at room temperature, rocking.
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At this point the hybridisation oven was set to 70°C. A proteinase K/PBT digest 
was set up at a concentration of 10pg/ml5 and to stop the proteinase K reaction a 
2mg/ml glycine (Sigma) and PBT solution was also prepared. The timing of 
digestion was incredibly critical, to ensure the embryos were not completely/under 
digested. The optimal digestion times for each embryonic stage are detailed in 
table 2.3. To perform the proteinase K reaction the PBT was removed and the 
embryos were incubated in proteinase K/PBT at room temperature for their allotted 
digestion time. Following incubation the proteinase K/PBT solution was removed 
promptly and the glycine/PBT solution was added in order to stop the reaction. The 
digested embryos were then incubated at room temperature, rocking; twice for 5 
minutes in glycine/PBT in order to make sure all proteinase K had been removed. 
They were then washed twice for 5 minutes in PBT, rocking. A post-fixative 
solution was prepared consisting of 4% PFA and 0.2% glutaraldehyde. The 
embryos were fixed again for 20 minutes at room temperature, rocking. They were 
then washed twice for 5 minutes in PBT. At this point the pre-hybridisation 
solution was prepared (2ml). This consisted of 50% Formamide (Fisher scientific), 
5x SSC (pH 4.5-5.0), 1% SDS, heparin (50pg/ml), yeast tRNA (5pg/ml) final 
concentrations. The embryos were transferred into small glass vials, which had 
been coated in Sigma Coat to prevent tissue sticking to them, and as much PBT as 
possible was removed. 300pl of pre-hybridization solution was added. This was 
mixed briefly and removed. It was replaced by the remaining TOOpl of pre­
hybridisation solution and the cap was fastened tightly. The embryos were 
incubated at 70°C in the hybridisation oven for at least 1 hour. During this time the 
hybridization solution was prepared (1ml). This consisted of 50% Fonnamide, 5x 
SSC (pH 4.5-5.0), 1% SDS, heparin (lOOpg/ml), yeast tRNA (lOpg/ml) (Roche)
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and 0.5(ig of Wtl probe final concentrations diluted in DEPC- H2O. Once the 
embryos have incubated remove as much pre-hybridisation solution as possible. I 
had to be very cautious here as the embryos tend to be transparent at this stage so it 
was easy to discard them with the solution if you were not careful! 300pi of 
hybridisation solution was added and mixed briefly. This was then removed and 
replaced by the remaining 700pl of hybridisation solution. The cap was again 
fastened tightly and the embryos were returned to the oven and incubated 
overnight at 70°C. The second day of this procedure began by preparing the wash 
solutions the use DEPC-treated solutions was no longer necessary. Solution 1 was 
made up to final concentrations of 50% Formamide, 5x SSC, 1% SDS diluted in 
H2O. This was pre-heated to 70°C. Solution 2 was made up to final concentrations 
of 0.5M NaCl, lOmM Tris-HCl, 0.1% Tween-20 diluted in H2O at room 
temperature. Solution 1/2 consisted of equal volumes of solution 1 and 2. This was 
pre-heated to 70°C. Solution 3 was made up of final concentrations of 50% 
Formamide, 2x SSC diluted in H2O. This was pre-heated to 65°C. After 
preparation of the solutions the procedure continued. Hybridisation solution was 
discarded as much as possible, ensuring the embryos remained in the glass vial. 
They were washed for 5 minutes in a small amount of pre-heated solution 1. This 
was removed and the embryos were washed twice for 10 minutes in solution 1 at 
70°C, rocking. They were washed in solution 1/2 for 10 minutes at 70°C. The 
embryos were then washed twice in solution 2 for 10 minutes at room temperature, 
rocking. At this point the hybridisation oven temperature was changed to 65°C and 
the RNAse/solution 2 mix was prepared. This was done by diluting RNAse A 
(lOmg/ml) to a final concentration of lOOpg/ml in solution 2 and pre-warming to 
37°C. The embryos were incubated in the RNAse A solution twice for 30 minutes
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at 37°C, rocking. They were then washed twice for 30 minutes in pre-heated 
solution 3 at 65°C, rocking. At this point embryo acetone powder was heat 
inactivated. A pinch of embryo acetone powder was suspended in 1ml 
TBST/Levamisole (Sigma) (1:500) and heated to 65°C for 30 minutes. The 
Levamisole was added in order to block endogenous alkaline phosphatase. The 
solution was centrifuged and TBST/Levamisole was discarded. After this 80% 
TBST/Levamisole, 20% BM blocking reagent, 0.01% heat inactivated sheep serum 
(HISS) (Sigma), and 0.5pi anti-DIG antibody (1:2000 dilution) was added to the 
embryo acetone powder. This was then incubated for 1 hour at 4°C, rocking. Once 
incubated the supernatant was collected. This contained the pre-absorbed antibody. 
After the embryos had been incubated in solution 3 they were washed in 
TBST/Levamisole three times for 10 minutes at room temperature, rocking. At this 
time the blocking solution was prepared (2ml). The final concentrations of the 
blocking solution were 70% TBST/Levamisole, 10% HISS and 20% BM blocking 
solution. The embryos were transferred into the blocking solution and incubated at 
room temperature for at least 1 hour, rocking. The blocking solution was then 
discarded and the embryos were incubated in the pre-absorbed antibody solution 
(1ml per vial) overnight at 4°C, rocking. The third day started with 3 brief rinses in 
TBST/Levamisole. This was followed by four 1 hour long washes with 
TBST/Levamisole at room temperature, rocking. Whilst the embryos were washing 
the NTMT (alkaline phosphatase buffer) was prepared (10ml). This was made to 
final concentrations of lOOmM NaCl, lOOmM Tris-HCl pH9,5, 50mM MgCb, 
0.1% Tween-20 diluted in H2O. After the last TBST/Levamisole wash the embryos 
were incubated in NTMT/Levamisole twice for 20 minutes at room temperature, 
rocking. They were then transferred to a 4-well dish, as much NTMT was removed
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as possible and 1 ml/well of BM purple alkaline phosphatase substrate (Roche) was 
added. They were mixed gently. The embryos were placed in a dark place and they 
were watched carefully for the colour' development. To stop the reaction they were 
washed twice for 10 minutes in NTMT at room temperature and then washed in 
PBT pH 5.5. This treatment was to reduce any purple background staining. The 
embryos were then post-fixed in 4% PFA/0.2% glutaraldehyde for 20 minutes at 
room temperature and then washed twice in PBT for 10 minutes.
In situ hybridisation on frozen sections
Sections were generated as previously described. Slides were transferred from the 
freezer (-80°C) to a slide box in cold conditions to avoid too much condensation 
developing on the sections. The slides were dried at 50°C for 15 minutes. Using 
glass trough, which held 200ml, the sections were post-fixed in 4% PFA for 20 
minutes. They were then washed twice in PBS. Following PBS washes they were 
carbethoxylated in active 0.1% DEPC-PBS twice for 15 minutes. This was done to 
decrease any background later on in the procedure. The sections were then 
equilibrated in DEPC-treated 5x SSC for 10 minutes. The slides were transferred to 
slide mailer boxes, which were sealed with parafilm, and they were pre-hybridised 
for 2 hours at 58°C in pre-hybridisation buffer. This consisted of final 
concentrations of 50% Formamide, lx SSC and 40pg/ml salmon sperm DNA 
(Sigma) which had been heat denatured for 10 minutes. This solution was diluted 
in RNAse free H2O. The sections were then hybridised in the hybridisation buffer, 
which contained the same ingredients as the pre-hybridisation buffer, listed above, 
with a final concentration of 0.4jig/ml DIG labelled probe added to it also. This 
was incubated overnight at 58°C. 300pl per slide of hybridisation buffer was used
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and the slides were covered in parafilm. The slides were placed in trays containing 
paper towels soaked in 50% Formamide and 5x SSC. The trays were then sealed. 
This was done to maintain a humidified environment in order to prevent the slides 
from drying out. From day 2 DEPC-treated solutions were no longer needed. Post­
hybridisation wash solutions were prepared and allowed to pre-warm before the 
procedure was continued. Antisense and sense probes were kept separate during at 
least the first wash step, to prevent contamination between the two. To continue the 
protocol the parafilm was removed from the slides and they were washed twice for 
30 minutes in 2x SSC at room temperature. They were then washed in 2x SSC for
1 hour at 65°C. After which they were washed in 0.2x SSC for 1 hour4 at 65°C. The 
slides were then washed in PBS/0.05% Tween-20 for 10 minutes at 65°C. Finally 
they were washed in PBS/Tween-20 for 10 minutes at room temperature. During 
this time the blocking solution was prepared. This contained final concentrations of 
lx PBS, 0.05% Tween-20, 5-20% sheep serum, 0.5-5% milk powder and was 
diluted in autoclaved H2O. The sections were incubated in the blocking solution for
2 horns at room temperature in humidified conditions. After this the sections were 
incubated overnight at 4°C in the same blocking solution as listed above, but also 
contained anti-DIG-AP (Roche) diluted to 1:5000. The third day began with three 
30 minute post-antibody washes in PBS/0.05% Tween-20 at room temperature. 
The slides were then equilibrated for 5 minutes in alkaline phosphatase buffer, 
which consisted of final concentrations of lOOmM Tris/HCl, lOOmM NaCl, 50mM 
MgCl2 diluted in autoclaved H2O at pH9.5. The sections were then incubated in 
developing solution. This was made by adding 45 pi NBT and 3 5 pi BCIP per 10ml 
alkaline phosphatase buffer. The slides were then incubated at room temperature in 
the dark for a few hours to overnight for developing to occur4, keeping watch over
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their progress, making sure they were not over-developed. This reaction was 
stopped by washing in PBS. The sections were then post-fixed in 4% PFA for 20 
minutes. They were washed in DEPC-FhO and dehydrated by submerging once in 
70%, 90%, twice in 100% ethanol and twice in Histoclear (National diagnostics) 
for two minutes each step. The slides were then mounted with Eukitt (Fluka) for 
imaging and prolonged storage.
2.5 Preparation of neural tube explants
The abdominal cavities of time-mated female mice were opened by making two 
incisions through the abdominal wall and underlying peritoneum, one horizontally 
and one vertically in the midline. The bicomuate uterus was dissected away from 
both ovaries and transected at the ceivix. The embiyos and uterus were placed in 
DMEM with 4500mg glucose/L, L-glutamine, NaEtCOs and pyridoxine.HCl 
(Sigma D5796) plus 10% neonatal calf serum (v/v) (NCS, Gibco) at 37°C. Glass 
cover-slips were coated in 0.5% gelatine. They were incubated at 37°C for one 
horn. The gelatine was then removed and replaced by DMEM plus 5% NCS (v/v) 
and 5% horse serum for immediate use. All maternal and extra-embryonic tissues 
were removed from each embryo using forceps (Fine Science Tools, size 55). The 
vagal neural crest was excised by removing all tissues rostral to somite one, and 
caudal to somite seven using tungsten needles. The embryonic pieces were then 
typsinised in 0.05% trypsin (in PBS, v/v) (Gibco) at 4°C for 30 minutes to 
dissociate all unwanted tissues i.e. somites, heart, underlying mesenchyme. After 
incubation in trypsin the samples were drenched in media plus serum and freed by 
micro-dissection from remaining surrounding tissues. The neural tubes were then
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transferred into 24 well plates with gelatine-coated coverslips containing pre­
warmed (37°C) DMEM (Sigma) plus 5% NCS and 5% horse serum (Sigma) 
(Jaenisch 1985) for overnight incubation.
Neural tube explants were photographed at specific time-points over a 7 day 
period. Cells were measured from the outer margin of the explant to the migration 
front (pm). This was calibrated against the scale bar. Each image was taken with a 
lOx objective and was scaled to 10cm by 7cm so they could be placed on to A4 
paper. The scale bar for each image was 200pm, which measured 15mm on the 
page, meaning each 1mm measured approximately 13 pm of migration. For 
example if a sample measured 10mm on the page then the calculation performed to 
convert this number to microns would be 200/15 x 10 = 133pm.
Neural tube explants were fixed for 10 minutes at room temperature in 4% PFA. 
Immunofluorescence was carried out at varying time-points following the protocol 
for immunofluorescence on frozen sections, described on page 50 of this thesis.
Sharpening tungsten needles
Tungsten wires were placed into metal holders. Protective gloves were worn 
throughout. A glass beaker was filled with sodium hydroxide (NaOH) and a large 
paper clip was hung over the side so that it was partially sub-merged. This acted as 
one electrode. Two wires were attached via crocodile clips to the positive and 
negative parts of a 9V battery. One wire was attached to the paperclip and the other 
wire was connected to the metal holder containing the tungsten wire, acting as the 
second electrode (Figure 2.1) (Brady 1965). The tungsten wires were sharpened to 
a fine point by quickly dipping the tip up and down in the NaOH. Tiny bubbles
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appeared when the tungsten wire was sub-merged indicating that the circuit was 
complete. The tungsten wire was examined under a dissecting microscope to gauge 
sharpness.
2.6 Culture of kidney-derived stem cells
Kidney-derived stem cells (KSC) were obtained from Dr Patricia Murray’s lab. 
University of Liveipool (Fuente Mora, Ranghini et al. 2011). KSC were seeded on 
8-well chamber slides in high glucose DMEM (Invitrogen) supplemented with 
2mM glutamine and 10% FCS. KSC were cultured until approximately 70% 
confluent.
SiRNA silencing of Wtl gene expression
This protocol was adapted from the original obtained from Dr. Michael Cross, 
University of Liverpool. Two sterile tubes each containing 50pi of Optimem media 
(Gibco/Invitrogen) were set up. To one of these tubes 0.5pi Lipofectamine 2000 
(Invitrogen) was added to give a final concentration of 0.1% v/v, to the other tube 
15pi siRNA duplex (lOpM stock solution) was added. The solutions were 
incubated at room temperature for 5 minutes. After incubation, the Lipofectamine 
mixture was slowly added to the tube containing the SiRNA (Qiagen). The 
solutions were mixed by gently pipetting up and down. This was then incubated for 
30 minutes at room temperature in order to allow the siRNA to form a complex 
with the Lipofectamine. Just prior to the end of this incubation, the chamber slides 
containing the KSC we prepared for transfection. This was achieved by aspirating 
the media and adding 0.4ml Optimem per chamber. 115pl of transfection mix was
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added slowly to each chamber to give a final volume of 515j.il. The chamber slide 
was then gently swirled to ensure the solutions were mixed sufficiently. The slides 
were then incubated for 4 hours at 37°C. After the incubation step the transfection 
mix was aspirated from the slides and the cells were washed twice with PBS 
containing Mg /Ca , whilst gently swirling the slides to ensure a thorough wash. 
The PBS Mg2+ /Ca2+ wash step was repeated. After the cells had been thoroughly 
washed the PBS was aspirated and 0.4ml of KSC media was added to the cells and 
they were returned to the incubator at 37 °C. After 48 hours in culture the cells 
were prepared for immunofluorescence as described on page 50 of this thesis.
2.7 Microscopy and image capture
Fluorescent microscopy was carried out on an upright Leitz DMRB (Leica 
microscope). Dissection of neural tube explants was conducted using a Leica 
M165FC dissection microscope. The migration of NCCs from neural tube explants 
was imaged using the inverted Leica DMIRB microscope. All images taken during 
these experiments were captured using Leica Application Suite V3 software. 
Confocal microscopy was carried out using the Leica DMIRE2 microscope and 
images were captured using Metamorph© software. Images were viewed and 
compiled using Adobe Photoshop and Illustrator CS2.
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2.8 General reagents and solutions
lOx Phosphate buffered saline (PBS), 1L
80g NaCl (Sigma), 2g KC1 (Sigma), 14.4g Na2HP04, and 2.4g KH2PO4 was added 
to 800ml H2O, pH adjusted to 7.4, filled to a final volume of 1L with H2O and 
autoclaved.
4% (w/v) paraformaldehyde (PFA), 100ml
4g PFA (Fisher scientific) was dissolved in 10ml 100ml lx PBS. This was sterile 
filtered and kept at 4°C for up to two weeks.
25% (v/v) Triton solution, 100ml
25ml Triton (Fluka) was added to 75ml lx PBS. This was further diluted in PBS to 
0.25% as a working solution,
2% (w/v) Bovine serum albumin (BSA) solution, 100ml
2g BSA (Fluka) was diluted in 100ml lx PBS at 37°C and then stored at 4°C.
DEPC-H20,1L
lOOpl (0.01% v/v) DEPC was added to 1L H2O. This was stirred over night at 
room temperature, then autoclaved
TE
lOmM Tris-HCl and 1M EDTA adjusted to pH 8.0
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Luria broth (LB), 100ml
2g LB dissolved in 100ml H2O
LB trans media
LB supplemented lOmM MgSCL, 10mM MgC^ and 20mM glucose. The high 
glucose content allows for bacterial recovery.
TENS buffer
TE, 0.1M NaOH and 0.5% (w/v) sodium dodecyl sulphate (SDS).
20x Sodium chloride, sodium citrate (SSC)
175.3g NaCl and 88.2g sodium citrate were dissolved in 800ml H2O, the pH was 
adjusted to 7.0, and the final volume was adjusted to 1L. Final concentrations were 
3.0M NaCl and 0.3M sodium citrate.
Sodium hydroxide (NaOH)
400g NaOH pellets (Fisher scientific) were slowly added to 800ml H2O, stilling 
continuously. The beaker was kept on ice and once the pellets had completely 
dissolved the volume was adjusted to 1L with H2O.
NB This is an exothermic reaction resulting in a large amount of heat energy which 
can break glass beakers. It is therefore prepared in a plastic beaker.
3M Sodium Acetate (NaAc)
246.09g NaAc (Sigma) was dissolved in 800ml H2O. The pH was adjusted to 5.2 
with glacial acetic acid and H2O was added to a final volume of 1L.
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lOx Tris-buffered saline (TBS), 100ml
8g NaCl, 0.2g KC1 and 25ml 1M Tris in H2O were adjusted to pH7.5 and H2O was 
added to make a final volume of 100ml.
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Table 2.1 Information on antibodies used throughout immunofluorescence 
experiments in this thesis
Primary antibodies
Name of 
Antibody
Polyclonal/
Monoclonal
Raised in Company Dilution
Wtl M Mouse Upstate 1 pg/ml or 1:500
Wtl P Rabbit Santa Cruz 1:200 -1:500
Sox 10 P Goat Santa Cruz 1:100
Hu M Mouse Invitrogen 200ng/ml or 1:50
P75 P Rabbit Abeam 1:500
Foxd3 P Rabbit Patricia Labosky 1:1000
B-Gal P Rabbit Cappel/ICN 1:5000
Tujl M Mouse Abeam 1:500
Secondary antibodies
Raised in Reacts against Company Spectral data Diluti
on
Donkey Rabbit Invitrogen Alexa fluor® 488 1:1000
Donkey Mouse Invitrogen Alexa fluor® 488 1:1000
Donkey Goat Invitrogen Alexa fluor® 568 1:1000
Goat Rabbit Invitrogen Alexa fluor® 488 1:1000
Goat Mouse Invitrogen Alexa fluor® 568 1:1000
Goat Rabbit Jackson
ImmunoResearch
Horse radish 
peroxidise (HRP)
1:500
Chicken Rabbit Invitrogen Alexa fluor® 488 1:1000
Chicken Goat Invitrogen Alexa fluor® 594 1:1000
4’,6-Diamidino-2-phenylindole (DAPI) Sigma 1:1000
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Table 2.2 Fixation times using 4% PFA for different mouse embryonic stages. 
Fixation times varied according to the size/stage of the embryo and the 
subsequent technique these are shown in the table below
Embryonic stages Immunohistochemistry In situ hybridisation
E7.5 30 minutes 30 minutes
E8.5 45 minutes 45 minutes
E9.5 1 hour 1 hour
E10.5 1 hour 1 hour' 15 minutes
E11.5-E14.5 1 hour 30 minutes -
E15.5 - E16.5 2 hours -
mouse embryos. Digestion 
embryo and are shown in
Embryonic stage Digestion times
E7.5 30 seconds
E8.5 45 seconds
E9.5 60 seconds
E10.5 90 seconds
Table 2.3 Optimal Protemase-K digestion times for 
times varied according to the size and stage of the 
the table below
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Needle
holder
Tungsten
wire
10% NaOH
Figure 2.1 Schematic diagram representing the apparatus needed to 
electrolytically sharpen tungsten wires for dissection techniques.
Figure adapted from Brady, 1965
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Chapter 3
Results
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3.1 The expression of Wtl in the developing enteric nervous system
Previous findings using the Wtl-Cre Rosa-26-R mouse line revealed that Wtl is 
expressed in the enteric nervous system (ENS) of the adult mouse (Figure 1.8). 
This result indicates that Wtl had to have been expressed in the ENS during its 
development from the neural crest. The aim of this chapter is to produce a time- 
course, which will show where Wtl is expressed and elucidate the time at which 
Wtl was expressed in NCCs during embryonic development and in particular the 
formation of the ENS. This was achieved by using immunofluorescence on tissue 
sections and whole mount immunohistochemistry to look at protein expression. 
Specific antibodies were used to locate NCCs within the mouse embryo, paying 
particular attention to the developing ENS when conducting co-staining 
experiments with Wtl antibodies. To study mRNA expression of Wtl, in situ 
hybridisation was employed. These experiments were carried out on frozen 
sections and whole-mount preparations generated from wild-type mouse embryos 
between embryonic stages E7.5 and El 6.5 the pattern of expression od Wtl was 
then documented.
3.2 Wtl expression in the developing mouse ENS at E16.5
According to the immunofluorescence data provided by B. Wilm (unpublished), [3- 
galactosidase, which marks Wtl-derived cells in the Wtl-Cre mouse, was found to 
co-localise with neuronal marker Hu in the intestinal plexuses of the newborn 
mouse gut (Figure 1.11). Wtl must have been expressed in the precursors of the 
ENS (NCCs) at a particular time-point in mouse embryonic development. To test 
this hypothesis I began by preparing sections of El6.5 mouse embryos for 
immunofluorescence and in situ hybridisation. Firstly, using antibodies against
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Wtl and the pan neuronal marker Hu to show the location of neuronal cells within 
the developing ENS, the immunofluorescence experiments confirmed that at El 6.5 
in mouse there is no expression of Wtl in the developing ENS (Figure 3.1). Wtl 
was found to be expressed in the nuclei of the mesothelial cells on the outer most 
margin of the intestine (Figure 3.1, A and C). Hu was expressed in the enteric 
neurons of the developing ENS. There was no co-localisation between Wtl and Hu 
at this time-point.
A similar* result was found when analysing Wtl and the neural crest/glial marker, 
SoxlO using immunofluorescence (Figure 3.2). SoxlO was expressed in the ENS 
(Figure 3.2, A and B). Wtl was expressed in the mesothelial lining of the gut and 
in the mesentery, which is a double layered sheet of mesothelial cells anchoring the 
intestinal tract to the posterior abdominal wall. The co-staining revealed that SoxlO 
and Wtl are mutually exclusive at this time-point.
In order to confirm that my Wtl probe generated for RNA in situ hybridisation was 
functional, I conducted experiments on frozen sections of El6.5 mouse. In the 
kidney region Wtl was found to be expressed in the glomeruli of the developing 
metanephric kidney (Figure 3.3, A). This Ending corresponds to that described in 
the literature (Armstrong, Pritchar*d-Jones et al. 1993). This indicated, therefore, 
that the antisense RNA probe was suitable for studying Wtl expression and 
investigating if Wtl is expressed in the ENS of the developing mouse.
As the Cre system had marked cells that were derived from cells that had to have at 
some time expressed Wtl, these results suggest that the expression of Wtl in the
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developing ENS must have occurred at an earlier time-point in development than 
E16.5.
3.3 Wtl expression in the developing ENS at E13.5
Following the results at El6.5, whereby Wtl was not found to be expressed in 
NCCs of the developing ENS, I decided to investigate the earlier embryonic stage 
of El3.5: Could this be the time-point at which Wtl was expressed within the 
developing ENS?
Using the Wtl probe I carried out RNA in situ hybridisation on frozen sections 
taken from El3.5 wild-type mouse embryos. The results from these experiments 
showed Wtl was expressed in the mesothelia surrounding the abdominal cavity 
and the intestine (Figure 3.4, A and B), in the gonad, the urogenital mesentery and 
developing metanephric kidney.
Looking at the protein expression of Wtl at this stage using immunofluorescence 
(Figure 3.5, A-C), Wtl protein matched the RNA in situ hybridisation data. Wtl 
expression was expressed in the mesothelia (Figure 3.5, A and C). Co-staining 
revealed the expression of the neural crest cell marker Sox 10, to be detected solely 
in the ENS region of the intestine (Figure 3.5, B and C). There was no co­
localisation between Wtl and SoxlO at this time-point within the ENS (Figure 3.5, 
C). I continued to use SoxlO as the marker for the ENS from this point onwards as 
it marks ENS precursors imlike Hu, which only marks cells with a neuronal fate.
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The findings were similar to those seen using immunofluorescence at El6.5, The 
results indicate that the expression of Wtl in the developing ENS must have 
occurred at an earlier embryonic stage to account for the co-expression of p- 
Galactosidase and the neuronal marker Hu in the ENS of the newborn Wtl-Cre 
mouse (Figure 1.11).
3.4 Wtl expression in the ENS at E12.5
As I was unable to detect Wtl within the ENS of the El3.5 mouse embryo, I 
prepared El2.5 mouse sections for Wtl and SoxlO immunofluorescence co­
staining. Wtl was detected in the same expression pattern as previously described 
in that it was expressed in the mesothelia surrounding the intraembryonic coelom 
and abdominal viscera (Figure 3.6, A-F). It was also expressed in the developing 
kidney and gonad (Figure 3.6, A and C). However, as was the case at El3.5 and 
El6.5 Wtl did not co-localise with SoxlO and was therefore not expressed in the 
ENS at this stage of development (Figure 3.6, A-F). These results indicate that an 
even earlier time-point must be considered to find expression of Wtl within the 
developing ENS.
3.5 Wtl expression in the developing ENS at El 1.5
Examining an earlier time-point still, I prepared El 1.5 mouse embryo sections for 
immunofluorescence. This was done in order to explore Wtl expression at this 
stage of development with the view to detecting Wtl within the ENS. Co-staining 
of Wtl and SoxlO revealed an extremely similar picture to that described at El2.5. 
Wtl was expressed in the mesothelium surrounding the abdominal cavity and its 
contents (Figure 3.7, A-F). There was no co-localisation between SoxlO and Wtl
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in the ENS of the midgut at this time-point (Figure 3.7, D-F). Wtl was also 
detected in the pleura enveloping the lungs and the mesothelium surrounding the 
oesophageal region of the foregut (Figure 3.8, A-C). However, co-localisation 
between Wtl and Sox 10 in the ENS of the foregut was not found (Figure 3.8, C). 
Putative expression of Wtl was also seen in the mesonephros, which is the 
developing urogenital system, and the gonadal ridge. The mesonephric tubules 
were negative for Wtl (Figure 3.8, D) as would be expected according to previous 
findings in the literature (Armstrong, Pritchard-Jones et al. 1993). Wtl was also 
detected in the epicardium of the heart (Figure 3.8, E). It is worth noting that 
Sox 10 was found to be expressed in the midgut. However, there was no Sox 10 
expression found in the hindgut (Figure 3.7, B and C). This corresponds to the 
literature, whereby NCCs have migrated through the entire foregut and have 
migrated through the caecum but have not yet reached the hindgut at this stage 
(Kapur, Yost et al. 1992; Young, Hearn et al. 1998).
These findings signify that in order to disclose expression of Wtl within the 
developing ENS investigation was required into the earlier embryonic stages of 
mouse development, starting with the examination of El 0.5 embryos.
3.6 Wtl expression in the developing ENS at E10.5
I conducted immunofluorescence experiments on frozen sections of El 0.5 mouse 
embryos, as my previous results had failed to show Wtl expression within the 
ENS. This suggested that Wtl must have been expressed earlier in development 
based on the (3-galactosidase expression in the ENS of the Wtl-Cre newborn 
mouse. My findings from experiments on El0.5 embryos revealed Wtl expression
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in the intermediate mesoderm, the mesothelium surrounding the foregut and body 
cavity, and in the epicardium lining the developing heart (Figure 3.9, A and C). 
Sox 10 positive NCCs migrating towards the foregut from the neural crest passed 
very closely to the Wtl-expressing intermediate mesodermal cells. However, they 
remained mutually exclusive (Figure 3.9, C and Figure 3.10, A-C). There was no 
co-localisation of Wtl and Sox 10 within the ENS of the foregut at this stage 
(Figure 3.9, C). Wtl was found to be expressed in the mesonephric mesenchyme, 
the dorsal mesentery anchoring the gut tube to the posterior abdominal wall, and in 
the mesothelium lining the coelomic cavity and the intestinal tract (Figure 3.10, D- 
F). There was no expression of Wtl found within the ENS distal to the heart region 
(Figure 3.10, F). These findings correspond to whole-mount RNA in situ 
hybridisation data (Figure 3.11, B). From the lateral aspect Wtl activity could be 
seen in the intermediate mesoderm along the length of the trunk, in the epicardium 
of the heart, in the septum transversum and intraembryonic coelom. However, all 
these findings suggest that Wtl expression in the developing ENS must have 
occurred even earlier in development.
3.7 Wtl expression in the developing mouse ENS at E9.5
My previous findings showed no expression of Wtl in the developing ENS 
between El6.5 and El0.5. This indicates that Wtl must have been expressed at an 
earlier time-point in ENS development. It has been reported by the use of 
immunohistochemistry, carried out by Anderson in 2006, that Sox 10-expressing 
neural crest cells pass through the region of the intennediate mesoderm during 
their migration to the foregut at E9.5 in the mouse (Figure 3.12, A). The 
intermediate mesoderm at this embryonic stage expresses Wtl (Figure 3.12, B).
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Following these findings it was hypothesised that, dining the migration of NCCs 
from the neural crest to the foregut, Wtl is up-regulated in these cells as they 
migrate through the already Wtl expressing intermediate mesoderm (Figure 3.12, 
C).
Immunofluorescence analysis was earned out on sectioned E9.5 mouse embryos 
using antibodies for Wtl and the migrating NCC marker Sox 10. Results from these 
experiments showed that Sox 10 positive NCCs do indeed pass through the 
intermediate mesoderm region (Figure 3.13, A, B, D and E). However, the Wtl 
positive and Sox 10 positive cells remained mutually exclusive in this area (Figure
3.13, A and D). Thus there was no co-localisation between Wtl expressing cells 
and neural crest cells at E9.5 in this area, at this time point. Immunofluorescence 
also revealed Wtl expression in the septum transversum (Figure 3.10, A), lining 
the intraembryonic coelom (Figure 3.14, A and C), in the mesonephros (Figure
3.14, B and D), and in the epicardium enveloping the heart (Figure 3.14, E). 
However, the distal portion of intestine and coelomic cavity was negative for Wtl 
(Figure 3.14, B). This is because this area was found to be initially devoid of 
mesothelium, but as development progresses mesothelial cells were found to 
migrate to and surround the gut tube (Wilm, Ipenberg et al. 2005).
This data indicated that an even earlier embryonic time-point must be investigated 
to find Wtl expression in the developing ENS. The literature has never reported 
expression of Wtl before E9.0 in the mouse (Armstrong, Pritchard-Jones et al. 
1993; Moore, Schedl et al. 1998). However, as the time-point at which Wtl was 
expressed in the developing ENS has not been determined from my findings so far,
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it can be assumed that Wtl must have been expressed at a time before NCCs had 
reached the foregut. It was therefore important to consider the E8.5 mouse embryo 
as a possible candidate for Wtl expression in NCCs that had just begun their 
migration to the foregut.
3.8 Wtl expression in NCCs of the developing E8.5 mouse embryo
Following my previous data collected between the embryonic stages of El6.5 and 
E9.5, which had revealed there to be no expression of Wtl in ENS precursors, I 
earned out whole-mount RNA in situ hybridisation for Wtl on E8.5 mouse 
embryos. This was done in order to determine if a signal for Wtl could be detected 
and if so to study where expression of Wtl was found. Wtl mRNA was expressed 
in the E8.5 mouse embryo (Figure 3.15, A). Wtl could be seen in the head and 
branchial arch region, in the neural folds, the primitive heart and caudal to the 
heart around the somites. Sections taken from the whole-mount preparations 
revealed Wtl in specific cells within the embryo (Figure 3.15, B-D). Wtl signal 
was localised to the neural folds and what looked like the neural crest region 
(Figure 3.15, C and D, figure 3.16, A-C). The negative controls showed no 
unspecific signal. This suggested that the Wtl signal detected in these experiments 
was not an artefact.
In order to confirm these results, whole-mount immunohistochemistry using horse­
radish peroxidise/DAB staining instead of a fluorophore was carried out on E8.5 
embryos to determine if there was Wtl protein being expressed. The results from 
this experiment tended to correspond with the in situ hybridisation data. Wtl signal 
was found in the neural folds (Figure 3.17, A). The dorsal surface of the embryo
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revealed staining for Wtl in what look like streams of cells migrating away from 
the neural tube. This was seen along the length of the closed part of the neural 
tube, including the region of interest, adjacent to somites 1-7 (Figure 3.17, B): This 
is the portion of crest that will go on to from the ENS (Yntema and Hammond 
1954). The negative control was clear (Figure 3.17, C). This suggested that this 
result was not an artefact.
Immunofluorescence was carried out on frozen sections taken from E8.5 mouse 
embryos. These were co-stained for Wtl and the neural crest cell marker SoxlO. 
Wtl was expressed in various cells throughout the E8.5 embryo, most importantly 
in the neural folds (Figure 3.18, A and B). Wtl was detected in cells in the region 
of the neural crest. The area contained within the orange box (Figure 3.18, B,D and 
F) contains 70 cells. Approximately 45% of these cells were SoxlO positive, 30% 
were Wtl positive. Approximately 20% of these cells were positive for both SoxlO 
and Wtl, 15% were sox 10 positive and Wtl negative, and 10% were Wtl positive 
and SoxlO negative. This suggested Wtl was being expressed in some NCCs at 
this stage (Figure 3.18, E and F).
In order to confirm this result and to determine if there was co-expression of the 
two proteins in the same cell nuclei, I used confocal microscopy to detect 
antibodies against Wtl and SoxlO (Figure 3.19). The results from this experiment 
revealed that Wtl and SoxlO were co-localising in the same cell nuclei of neural 
crest cells (Figure 3.19, A). Out of the 190 cells in the field of view (Figure 3.19) 
Wtl was found in the nuclei of approximately 30% of cells (Figure 3.19, A and C). 
However, there was also some Wtl staining seen in the cytoplasm of these cells.
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Approximately 35% of the cells in the neural crest region were Sox 10 positive 
(Figure 3.19, B) and, therefore, were NCCs. Around 20% of NCCs expressing 
Sox 10 also expressed Wtl (Figure 3.19, A). Approximately 5% were Sox 10 
positive and Wtl negative, and around 10% were Wtl positive and SoxlO negative 
(Figure 3.19, A). The negative controls did not reveal any unspecific staining 
(Figure 3.19, D and E). These results further indicate that Wtl is expressed in a 
population of neural crest cells at E8.5.
3.9 Differential expression of Wtl proteins detected with Wtl antibodies
The immunofluorescence data described in this chapter were obtained by using 
both the polyclonal rabbit Wtl antibody (Santa Cruz) and the monoclonal mouse 
Wtl antibody (Upstate). Throughout these studies both the polyclonal and 
monoclonal antibodies could be used to detect Wtl protein between El6.5 and 
E9.5 (Figure 3.20, A and B). However, at E8.5 and E7.5 the monoclonal antibody 
failed to detect genuine nuclear Wtl activity (Figure 3.20, C and D). This 
observation leads to the question: Why this there a difference between the two 
antibodies at these early embryonic time-points?
The data from E8.5 mouse embryos combined indicate that Wtl is expressed in 
NCCs that will go on to form the ENS in mouse. Therefore, LacZ and p- 
Galactosidase expression found in the ENS of adult and new-born mice (Figure 1.7 
and Figure 1.10) appeal's to originate from this early stage of neural crest 
fonnation. The question arises from these results: Is Wtl expressed at earlier time- 
points in neural crest cells?
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3.10 Wtl expression in the E7.5 mouse embryo
In order to investigate if Wtl was expressed at an earlier time-point than E8.5 I 
carried out whole-mount in situ hybridisation on E7.5 mouse embryos (Figure
3.21) . The results from these experiments revealed Wtl was expressed in the 
neural folds and underlying mesenchyme (Figure 3.21, A and B). The negative 
control was clear, which suggests this result is authentic.
I carried out immunofluorescence experiments for Wtl and SoxlO at E7.5 (Figure
3.22) . The results from these experiments showed that Wtl is expressed in the E7.5 
mouse embryo (Figure 3.22, A). Wtl expression was found in the nuclei of cells 
within the primitive streak, neuroepithelium, intraembryonic mesoderm, and in 
embryonic endoderm (Figure 3.22, A, C and D). There was also cytoplasmic Wtl 
staining found in the cells in these regions (Figure 3.22, D arrows). However, co­
staining with SoxlO revealed there was no expression of SoxlO at this time point 
(Figure 3.22, B, C and D). The negative controls from this experiment did not 
reveal any unspecific staining suggesting the results were genuine.
3.11 Conclusion
The findings presented in this chapter lead me to the conclusion that Wtl is 
expressed in the NCCs, some of which will migrate to the gut to form the ENS. 
Importantly Wtl expression is transient in these NCCs at E8.5, since at E9.5 there 
if no longer any Wtl detected in ENS precursors within the gut tube. This 
observation leads to an important question: If Wtl is expressed in NCCs along the 
neural crest at E8.5, what is its role in these cells?
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Figure 3.1 Immunofluorescence for Wtl and Hu in E16.5 mouse intestine
The schematic image of an El 6.5 mouse embryo shows the level at which Images 
A-F were taken, this is represented by a blue line (Kaufmann 1992). Image A is a 
composite image showing Wtl (green, arrows) in the mesothelia, the neuronal 
marker Hu (red, arrowheads) in the ENS, and the nuclear marker DAPI (blue) 
showing the structure of the gut section. Image B shows Hu (red) in the ENS only. 
Image C shows Wtl (green) in the mesothelia surrounding the gut. There is no 
expression of Wtl within the ENS. Images D-F show negative controls. Image D is 
DAPI showing cell nuclei. Image E shows Alexa fluor 488 goat anti rabbit and 
Image F shows Zenon IgG2b 488. All images were taken with a 40x objective. L, 
lumen. Scale bars 50pm (A-C) 100pm (D-F).
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Figure 3.2 Immunofluorescence for Wtl and SoxlO in the intestine at E16.5
The sections were taken from a similar level to that shown on the schematic 
diagram in Figure 3.1. A is a composite image showing expression of Wtl (green, 
arrows) in the mesothelia and the ENS precursor marker SoxlO (red, arrowheads) 
in the ENS. Image B shows SoxlO staining. Image C shows Wtl staining. DAPI is 
shown in blue (A-C). There is no Wtl expression in the ENS. D-F are images of 
the negative controls. DAPI is shown in D. Alexa 488 donkey anti rabbit is shown 
in E. Alexa 568 donkey anti goat is shown in F. The negative controls do not show 
any unspecific staining. All images were taken with a 20x objective. L, lumen, m, 
mesentery. Scale bars SOpm (A-C) lOOgm (D-F)
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Figure 3.3 Wtl in the kidney at E16.5
Wtl RNA in situ hybridisation on transverse sections through El6.5 kidney (A and 
B) using an antisense probe (A) and sense probe as the negative control (B). A 
shows Wtl activity in the developing nephron (gl). B shows some back ground 
staining but there is not specific Wtl signal. The arrowheads show dirty patches on 
the microscope objective. A was taken with a 40x objective and B was taken with a 
lOx objective. Scale bars 50pm (A) 100pm (B)
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Figure 3.4 Wtl in the E13.5 mouse embryo
Images A-D show Wtl RNA in situ hybridisation on transverse sections through 
the gastrointestinal tract of El3.5 mouse embryos. An antisense probe was used in 
images A-C and the negative control is shown in image D using a sense probe. 
Wtl is seen in the mesothelia surrounding the duodenum (d, image A), in the 
gonad (g), in the developing metanephric kidney (m), the urogenital mesentery 
(um, image B), and in the mesothelia surrounding the midgut (mg, image C). Wtl 
is not found in the region of the ENS. The negative control shows some 
background staining but no unspecific Wtl signal (D). Images A-D were taken 
using a 20x objective, ua, umbilical artery. Scale bars 50pm (A and D) 100pm (B 
and C).
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Figure 3.5 Wtl and SoxlO expression in the E13.5 mouse intestine
The blue line shown on the schematic diagram of El3.5 mouse embryo represents 
the level at which the sections were taken in images A-F (Kaufmann 1992). A-F 
were taken with a 40x objective and are immunofluorescence images showing Wtl 
(green, white arrows, A), SoxlO (red, white arrowheads, B), and a composite (C). 
DAPI is shown in blue (A-C). There is no Wtl staining in the ENS. D-F show 
images taken of the negative control. DAPI is seen in D. E shows Alexa 488 
donkey anti rabbit and F shows Alexa 568 donkey anti goat. No unspecific staining 
is seen in the controls (E and F). L, lumen, aw, abdominal wall. Scale bars 50pm 
(A-F).
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Figure 3.6 Wtl expression and the ENS at E12.5
Images A-F show immunofluorescence on transverse sections through El3.5 
embryos co-stained with polyclonal antibodies against Wtl and SoxlO. A-C were 
taken with a lOx objective and D-F were taken with a 40x objective. A and D show 
Wtl expression (green). B and E show SoxlO expression (red, arrowheads). C and 
F are composite images. Wtl is expressed in the mesothelia (arrows) surrounding 
the stomach (s) (A and C), the intestine (D and F), the abdominal cavity and the 
omentum (o) (A and C). Wtl is also expressed in the mesonephros (m) and the 
gonad (g) (A and C). There is no expression of Wtl in the ENS (C and F). Images 
G and H were taken with a 10 objective. They are negative controls showing Alexa 
488 donkey anti rabbit (G) and Alexa 568 donkey anti goat (H). There is a very 
small amount of background seen in image G. L, lumen. The blue line on the 
schematic image of an E12.5 mouse embryo (Kaufmann 1992) represents the level 
at which the sections were taken from in images A-H. Scale bars 200pm (A-C and 
G-H) 50pm (D-F)
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Figure 3.7 Wtl in the ENS at E11.5
Images A-F show immunofluorescence images co-stained for Wtl (green) and the 
ENS precursor marker SoxlO (red) in transverse sections. DAPI is shown in blue. 
Images A-C were taken with a lOx objective. Images D-F were taken with a 40x 
objective. A and D show expression of Wtl. B and E show expression of SoxlO. C 
and F are composite images. Wtl is seen in the mesothelium surrounding the 
abdominal viscera (arrows). SoxlO is seen in the ENS and plexi in the body wall. 
SoxlO is not expressed in the hindgut (*). Wtl is not co-expressed with SoxlO in 
the ENS (C and F). G and H show the negative control. Alexa 488 donkey anti 
rabbit (G). Alexa 568 donkey anti goat (G). The blue line on the schematic image 
of an El 1.5 mouse embryo (Kaufmann 1992) represents the level at which the 
sections were taken from in images Adi. s, stomach, mg, midgut. 1, liver. Scale 
bars 100pm (A-C and G-H) 50pm (D-F)
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Figure 3.8 Wtl expression at E11.5
Images A-E were generated using immunofluorescence using polyclonal 
antibodies against Wtl (green, arrows) and SoxlO (red, arrowheads). A-C are 
transverse sections at the level of the lungs. A shows Wtl. B shows SoxlO. C is a 
composite image. Wtl is expressed in the mesothelial cells of the pleura, 
surrounding the foregut (fg) and liver (li). There is no nuclear Wtl staining in the 
ENS. D is a transverse sections at the level of the developing kidneys. Wtl is 
expressed in the mesonephros and genital ridge. The mesonephric tubules are 
negative for Wtl. E is a transverse section through the heart, Wtl is expressed in 
the epicardium. The blue lines on the schematic image of an El 1.5 mouse embryo 
(Kauffnann 1992) represents the level at which the sections were taken from in 
images A-E. Images A-E were taken using a lOx objective, lu, lung, da, dorsal 
aorta. Scale bars lOOjam (A-E).
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Figure 3.9 Wtl and SoxlO at E10.5
The blue line on the schematic image of an El 0.5 mouse embryo (Kaufmann 1992) 
represents the level at which the section shown in this image was taken. The image 
shows immunofluorescence on a transverse section at the level of the heart and 
foregut in an El0.5 mouse embryo co-stained using antibodies against Wtl (green) 
and SoxlO (red). DAPI is shown in blue. Wtl is expressed in the intermediate 
mesoderm (im) and in mesothelial cells of the epicardium and those surrounding 
the foregut (arrows). There is no co-localisation between SoxlO and Wtl in the 
ENS of the foregut. The boxed area surrounding the intermediate mesoderm is 
shown at high magnification in Figure 3.10 (A-C). All images were taken using a 
lOx objective, fg, foregut. t, trachea, h, heart. nt5 neural tube. Scale bars 100pm (A- 
C).
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Figure 3.10 Wtl and SoxlO expression at E10.5
Images A-F are immunofluorescence using polyclonal antibodies for Wtl 
(green) and SoxlO (red). A-C were taken in the region of the intermediate 
mesoderm (im). The level at which these sections were taken from is 
represented on the schematic diagram on Figure 3.9. There is no co­
localisation between Wtl (arrow) and SoxlO (arrowhead) (C). D-E were 
taken at the level of the developing kidney. This region is represented by the 
blue line on the schematic diagram (Kaufmann 1992) Wtl is expressed in the 
mesonephric mesenchyme (m), the genital ridge (gr), and the mesothelium 
surrounding the gut and coelomic cavity (cc). SoxlO is seen in the ENS in 
the midgut (mg) region and in sacral neural crest cells in the caudal most part 
of the embryo (E and F). There is no co-localisation between SoxlO and Wtl 
in the ENS (F). G and H show the negative controls taken with a lOx 
objective. G shows Alexa 488 donkey anti rabbit and H shows Alexa 568 
donkey anti goat. Images A-C were taken with a 40x objective, images D-E 
with a lOx objective. Scale bars 50pm (A-C) 200pm (D-F and G-H)
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Figure 3.11 Whole-mount in situ hybridisation at E9.5 and E10.5.
A and B shows Wtl mRNA expression (yellow arrows) taken with a 4.Ox 
objective. Wtl is seen in the intermediate mesoderm (im), the epicardium (h), the 
septum transversmn, and the region of the septum transversum (st) at both E9.5 (A) 
and El0.5 (B). Trapping is seen in the otic vesicle (ov). This is not positive for 
Wtl, 1, first branchial arch. 2, second branchial arch, fb, forelimb bud. hb, hind 
limb bud. b, brain. Scale bars 500pm.
104
105
Figure 3.12 Wtl and SoxlO in the region of the intermediate mesoderm
A is an image adapted from Anderson 2006 and shows antibody staining of SoxlO 
positive NCCs migrating to the foregut (red arrows). B is an immunofluorescence 
image, taken with a 20x objective, showing the expression of Wtl in an E9.5 
mouse embryo. Wtl (green) is expressed in the intermediate mesoderm (white 
arrow) and the mesothelial cells of the coelomic cavity. C is a schematic diagram 
showing Wtl expression (green) and the migratory pathway of SoxlO expressing 
NCCs migrating towards the foregut (orange). NT, neural tube. FG, foregut. DA, 
dorsal aorta. Scale bar 100pm.
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Figure 3.13 Wtl expression and migrating NCCs at E9.5
The schematic diagram of an E9.5 embryo was adapted from Kaufman, 1992. The 
blue line indicates the level at which the sections were taken from in images A-F. 
A-C are immunofluorescence images taken with a lOx objective. D-F were taken 
with a 40x objective of the area marked with the grey boxes in A-C. A and D are 
composite images showing Wtl (green, arrows) expression in the intermediate 
mesoderm (A, star) and lining the coelomic cavity, Sox 10 (red, arrowheads) 
expression in NCCs migrating through the region of the intermediate mesodenn. B 
and E show SoxlO only. C and F show Wtl only. DAPI is shown in blue (A-F). 
There is no co-expression of Wtl and SoxlO in the region of the intermediate 
mesoderm at E9.5. NT, neural tube. FG, foregut. Scale bars 100pm (A-C) 50pm 
(D-F).
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Figure 3.14 Wtl expression at E9.5
Images A-E are immunofluorescence using the polyclonal Wtl antibody. A,B and 
E were taken with a lOx objective. C and D were taken with a 4Ox objective and 
are high magnification images of the boxed areas seen in A and B. DAPI is shown 
in blue. A and C show Wtl expression in the intermediate mesoderm (im) and 
surrounding the intraembryonic coelom (ic). B and D show expression of Wtl in 
the mesonephric mesenchyme (m). The mesothelium has not migrated over the 
midgut (mg) region at this stage so is therefore negative for Wtl (B and D, red 
arrows). The mesonephric tubules (mt) are also Wtl negative (D, red arrows). 
Image E shows Wtl expression in the mesothelial cells of the epicardium. The 
schematic diagram of an E9.5 embryo was adapted from Kaufinan, 1992. The blue 
lines indicates the levels at which the sections were taken from in images A-E. nt, 
neural tube. foregut. da, dorsal aorta, h, heart. Scale bars 100pm (A,B and E) 
50 pm (C and D)
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Figure 3.15 The expression of Wtl at E8.5
Wtl RNA In situ hybridisation on a whole-mount E8.5 embryo is shown in image 
A from a lateral aspect. Expression is seen in the region of the primitive heart (h) 
the first branchial arch (1), and in the region of the neural folds. The blue lines 
represent the level at which the sections seen in figure 3.16 (i) and B-D (ii) were 
taken. B is a 20pm section taken from the whole-mount. It was taken with a lOx 
objective. The grey boxes represent the area seen in images C and D, which were 
taken at a higher magnification using a 40x objective. Wtl activity (arrowheads) is 
seen in the neural folds (B-D), around the foregut (fg) (B), and in the region of the 
neural crest (B-D). Image E shows the sense control from a ventral aspect taken 
with a 4x objective. Image F shows a comparison between sense control and 
antisense samples from a dorsal aspect. There appeal’s to be no unspecific staining 
in the negative controls (E and F). so, somite, n, notochord, op, optic pit. Scale bars 
50pm (C and D), 100pm (B) 200pm (A).
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Figure 3.16 Wtl in the neural crest at E8.5
A-C are images taken from sections the whole-mount preparations of Wtl RNA in 
situ hybridisation (Figure 3.15). A was taken with a 20x objective. B and C were 
taken with a 40x objective, and are high magnification images of the boxed areas 
seen in image A. Wtl mRNA was found in the region of the neural crest and in 
cells in the neural fold (arrows). N, notochord. FG, foregut. np, neural plate, op, 
optic pit. Scale bars 100pm (A) 50pm (B and C).
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Figure 3.17 Wtl expression in the neural crest at E8.5
A and B are immunohistochemistry images of E8.5 whole-mount preparations 
using antibodies against Wtl. A was taken with a 5x objective. B was taken with 
an 11.5x objective and is a high magnification image of the boxed area seen in A. 
Somites 1-7 are shown with arrows (A). Wtl staining can be seen in the region of 
the neural crest lateral to the neural tube (B, arrows). Image C is a comparison 
between the negative control (bottom) and Wtl sample (top) taken from a lateral 
aspect. The control is clear' (C). Scale bars 500pm (A and C) 200pm (B).
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Figure 3.18 Wtl expression in NCCs at E8.5
Images A-F show immunofluorescence using Wtl (green) and SoxlO (red) 
antibodies. A, C, E were taken with a 20x objective. B, D, F were taken using a 
40x objective and are high magnification images of the area inside the grey boxes 
shown in A, C and E. A and B show Wtl only. C and D show SoxlO only. E and F 
are composite images showing Wtl expression in the region of the neural crest and 
neural folds and co-expression of Wtl with SoxlO. DAPI is shown in blue (A-F). 
Wtl and SoxlO co-localise in neural crest cells at E8.5 (yellow arrows). The 
orange box in images B, D, and F shows the area of neural crest from which cells 
were counted. NP, neural plate. FG, foregut. Scale bars 50pm. See Figure 3.19 for 
a diagram to show the levels at which these sections were taken from.
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Figure 3.19 Co-localisation between Wtl and SoxlO in NCCs
The schematic diagram of an E8.5 embryo was adapted from Kaufman, 1992. The 
blue line indicates the level at which the sections were taken from in images A-E. 
Images A-C were taken using confocal microscopy using a 63x oil objective. A is a 
composite image showing immunofluorescence for Wtl (green) and SoxlO (red). 
B shows Wtl only. C shows SoxlO only. DAPI is shown in blue (A-C) Wtl co­
localises with SoxlO at E8.5 in NCCs (white arrows). Red arrows show examples 
of SoxlO positive cells that are not Wtl positive. Images E and F show negative 
controls taken with a 20x objective. Alexa 488 chick anti rabbit (E). Alexa 594 
chick anti goat (F). Scale bars 100pm
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Figure 3.20 Differential staining with Wtl antibodies at E8.5
Images A and C are immunofluorescence using the polyclonal Wtl antibody 
(Santa Cruz). B and D are immunofluorescence using the monoclonal Wtl 
antibody (Upstate). A and B were taken with a lOx objective and show very similar 
expression patterns between Wtl polyclonal (A) and monoclonal (B) antibodies. 
The signal is nuclear and matches that previously reported. C and D were taken 
with a 40x objective. Wtl staining is nuclear in C using the polyclonal antibody. 
However, there is no nuclear staining in D using the monoclonal antibody. The 
negative controls do not show unspecific staining (E and F). Alexa 488 goat anti 
rabbit (E). Alexa 568 goat anti mouse (F). Scale bars 100pm (A and B) 50pm (C 
and D) 200pm (E and F)
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Figure 3.21 Wtl expression at E7.5
Images A-C are Wtl RNA in situ hybridisation on whole-mount E7,5 embryos. A 
and B show hybridisation with the antisense probe. C shows the control, which was 
hybridised with the sense probe, A is a lateral view and B is a ventral view, both 
show Wtl in the neural folds (nf) and underlying mesenchyme. The negative 
control is a ventral view and is negative for unspecific staining (C). Scale bars 
100 pm
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Figure 3.22 Wtl and the neural crest at E7.5
A-C, E and F are immunofluorescence images taken with a 20x objective and 
image D was taken with a 40x objective. A shows Wtl only. B shows Sox 10 only. 
C is a composite image of Wtl (green) and SoxlO (red) DAPI (blue). D is a high 
magnification image of the boxed area in C. There is no expression of SoxlO at 
E7.5 (B and C). Wtl is expressed in many cells at E7.5 (A and C). The schematic 
diagram of an E7.5 embryo was adapted from Kaufman, 1992. The blue line 
indicates the approximate level at which the sections were taken from in images A- 
F. D and E are negative controls. Alexa 488 donkey anti rabbit (D). Alexa 568 
donkey anti goat (E). The controls show no unspecific staining except for a dirt 
particle, which has caused the green (D) and red (E) spots, ng, neural groove, ne, 
neuroepithelium. ac, amniotic cavity, ps, primitive streak, ee, embryonic 
endoderm. iem, intraembryonic mesoderm, hi, blood island. *, junction between 
neural and surface ectoderm. Scale bars 50pm.
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Chapter 4
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An in vitro system to analyse Wtl expression in Vagal NCCs
My previous results showed that Wtl is expressed in neural crest cells (NCCs) at 
E8.5. Therefore, it raised the question of whether there is a role for Wtl in these 
NCCs, particularly the cells destined to migrate to the gut to form the enteric 
nervous system. In order to investigate this, an in vitro system was to be employed. 
The intention of this study is to produce a system that could eventually, once 
optimised, be used to find a role for Wtl in migrating NCCs by looking at the 
functional consequences of Wtl knock down on NCC migration and differentiation 
using siRNA. It was first necessary to establish in vitro the culture of neural crest 
explants i.e. a method of dissection of the neural tubes and the necessary culture 
conditions. It was then important to determine whether the cells that emerged from 
the neural tube explants were in fact NCCs, if they still expressed Wtl even under 
in vitro conditions and to establish a method to measure their migration in addition 
to assessing their differentiation using marker expression.
4.1 Development and optimisation of a NCC in vitro culture system
There are several methods for preparing neural tubes for NCC culture. The initial 
method used in these experiments was derived from several protocols described by 
Bronner-Fraser in 1996, Stemple in 1992, and Barlow in 1998. The vagal level of 
neural tube (opposite somites 1-7) was dissected from E8.5 mouse embryos using 
sharpened tungsten wire (Stemple and Anderson 1992; Bronner-Fraser 1996; 
Barlow, Wallace et al. 2008). Based on these published methods my early 
experiments failed to show any cells emerging from the explants (Figure 4.1). 
These explants had been plated onto glass cover-slips, previously coated with 
either fibronectin at a concentration of lOpg/ml and poly-L-lysine at a
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concentration of 10|ag/ml (Bronner-Fraser 1996; Barlow, Wallace et al. 2008). The 
neural tubes were dropped onto the cover-slip in a small amount of culture 
medium, DMEM supplemented with 10% NCS, in order to allow the neural tubes 
to attach to the substrate. However, the cells had the appearance of having died and 
because there had been no expansion of the culture over a period of 7 days it was 
assumed that this was the case, and therefore the culture conditions needed 
adjusting (Figure 4.1 A and B).
Following the failure of these initial experiments the literature was searched once 
again and a method described by Jaenisch in 1985 was found in which glass cover- 
slips were now coated in a 0.5% gelatine solution (in PBS). The neural tubes were 
dissociated from surrounding tissues using a 0.05% (w/v) trypsin solution (in PBS) 
at 4°C for 30 minutes, before dissection with sharpened tungsten needles (Jaenisch 
1985). It was also decided, after the failure of the previous method, to place the 
neural tubes directly into 500pl of culture media. This allowed the explants to sink 
and attach to the cover-slip without drying out. This proved to be a success and 
cells began to emerge from the neural tube pieces and over a period of several days 
the migratory population of cells expanded, which suggested the cells were 
undergoing proliferation (Figure 4.2).
With a working method of preparation of NCCs in culture, attention was turned to 
their culture conditions i.e. media. When using DMEM plus 10% NCS (v/v) the 
morphology of the emerging cells was not optimal. After 48 hours in culture the 
migrating cells had many vacuoles, the cell population was expanding quite slowly 
and did not look like migrating cells seen in similar assays in the literature (Ito and
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Takeuchi 1984; Jaenisch 1985; Stemple and Anderson 1992; Bronner-Fraser 
1996). The explant had also disintegrated (Figure 4.2, A). According to the 
protocol published by Jaenisch the media was then changed to DMEM 
supplemented with 5% NCS and 5% horse serum (Jaenisch 1985). The cell 
morphology appeared considerably healthier in these conditions as there were far 
fewer vacuoles and after 48 hours under these culture conditions the cell 
population was still expanding and the central neural tube explant remained intact 
(Figure 4.2, B).
4.2 Confirmation that migrating cells are NCCs
It was essential to establish if the cells that emerged from the neural tube explants 
were NCCs. In order to address this question immunofluorescence using antibodies 
to known markers for migrating NCCs, SoxlO, was performed. Sox 10 was found 
to be expressed by a proportion of the migrating cells (Figure 4.3 A-C). This 
suggested that they were NCCs. However not all of the cells in the culture 
expressed SoxlO, which suggested some of the cells were either not NCC derived, 
or they had lost their NCC properties during the culturing process.
4.3 Wtl is expressed in NCCs in culture
To test if these cells expressed Wtl as shown in vivo immunofluorescence was 
carried out after 24 hours in culture. This was done using the polyclonal rabbit 
antibody for Wtl (Figure 4.4). Wtl was found to be expressed in around half of the 
NCCs migrating away from the neural tube explant (Figure 4.4, B, C, E and F). 
The neural tube explant had detached from the cover-slip during the staining 
procedure, however a small proportion of the cells remaining on the substrate
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where the neural tube had been also expressed Wtl but there were fewer cells 
expressing Wtl here than in the migrating cells.
4.4 Time-course of NCC behaviour and Wtl expression in culture
In order to determine the most suitable time-point at which attempt to knock-down 
Wtl, the behaviour of the NCCs was characterised and the expression of Wtl was 
documented over a period of 7 days.
Characterisation of NCCs after 24 and 48 hours in culture
Following 24 hour’s in culture the neural tube explants were photographed and then 
fixed for immunofluorescence. The neural tube pieces became rounded when in 
culture and did not maintain their original tube like structure (Figure 4.5, A). The 
cells that were just emerging from the neural tube had an epithelial-like 
morphology. In fact, the entire outer border of the neural tube became distorted and 
was found to form what appeared to be a flattened epithelial expanse (Figure 4.5, 
A). The first cells to migrate away from the neural tube had multiple processes 
(Figure 4.5, B-G). These findings correspond to the work of Ito and Takeuchi in 
1984. They found similar phenotypes when looking at the migration and 
differentiation of NCCs in vitro, referring to the migrating cells with multiple 
processes as “stellate cells” (Ito and Takeuchi 1984).
Using antibodies against Wtl and neural crest markers p75 and SoxlO, 
immunofluorescence was carried out. The results from this provided further 
evidence that the migrating cells are neural crest-derived, and there are still 
undifferentiated NCCs after 24 hours in culture, as both SoxlO and P75 markers
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were expressed in these migrating cells (Figure 4.6, A-D) (Young, Ciampoli et al. 
1999; Hong and Saint-Jeannet 2005). As described in the previous paragraph, Wtl 
was also expressed in around half of the migrating cells after 24 hours in culture 
(Figure 4.4). Therefore, NCCs have an intrinsic expression of Wtl, which was not 
induced by their environment in vivo.
The aforementioned results were similar to those seen after 48 hours in culture, 
(Figure 4.7, A). However, unlike the relatively uniform morphology of the 
migrating cells after 24 horn's, at 48 hours approximately a third of cells had begun 
to develop long axonal-like processes (Figure 4.7, B-F) suggesting the NCCs were 
beginning to differentiate into what looked like neuronal cells. Data from 
immunofluorescence showed that Wtl was still expressed in around half of cells of 
the migrating population, a proportion of these cells expressed cytoplasmic Wtl 
(Figure 4.8, A-C), and the neural crest marker, Foxd3, was still being expressed in 
around 30-40% of these cells (Figure 4.3, D-F). However, the neuronal marker, 
Tujl, was also being expressed in a number of the cells (Figure 4.8, D-F). Tujl 
was detected exclusively in the processes of the neuronal-like cells observed with 
bright-freld. These results confirmed that after 24 hours and up to 48 hour’s in 
culture the in vitro population of NCCs began to differentiate into neuronal cells or 
due to the whole neural tube being dissected and placed into culture, some of the 
neuronal cells could be developing motor neurons, projecting from the ventral 
aspect of the spinal cord. Further investigations would have to be canted out using 
specific markers to sensory neurons. Table 4.1 shows a comparison between 24 
and 48 hours in culture.
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Table 4.1 A comparison of data collected from neural crest cell explants at 24 
hours and 48 horn’s of culture.
24 hours 48 hours
Explant appearance Rounded explant Explant margins:
Border of migrating cells Less defined
Migration (pm) 139 304
Cell shape Uniform More irregular* pattern
Foot-like processes Neurite outgrowth
Stellate cells Fewer stellate cells
Expression pattern
P75 ✓ ✓
SoxlO ✓
Foxd3 7 S
Tujl X
Wtl ✓ ✓
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Characterisation of NCCs after 72 and 96 hours in culture
Analysis of cells in the cultured explants at 72 and 96 horn's revealed that the cell 
morphology remained very similar during this time period. There were still a 
number of stellate-like cells with multiple processes migrating further away from 
the central piece and this still had the epithelial-like sheet surrounding it. However, 
at 72 hour's the neural tube piece appeared to start to disintegrate (Figure 4.9, A). 
This result suggested that the neural tube explant could not be maintained in long 
term culture, under these conditions. The most significant difference between these 
stages and 48 hours in cell morphology was that the axon-like processes (Figure 
4.9, B) projecting from the developing neuronal cells, which were now present on 
the majority of the cells in the culture, had started to form networks, which had the 
appearance of plexuses (Figure 4.9, C).
It was foimd that Wtl was still expressed in around a quarter of migrating cells 
(Figure 4.10, A and B). Around a fifth of the total migratory cell population were 
still NCCs, as they were also expressing SoxlO (Figure 4.10, D and E, Figure 4.3, 
G-I). The vast majority of Sox 10-expressing cells also expressed Wtl. However 
there was a small proportion of Wtl-expressing cells which did not express SoxlO. 
Approximately half the total number of migrating cells did not express either Wtl 
or SoxlO at 96 hour's in culture.
The neuronal marker, Tujl, was still expressed by the developing neuronal cells 
(Figure 4.11). Tujl was still foimd to be exclusive to the increasing number* of 
processes of the cells with neuronal morphology. The plexus-like formation of the
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processes was also apparent with Tujl (Figure 4.11, B). However, these cells could 
also be motor neurons projecting from the spinal cord.
Characterisation of NCCs after 120 and 168 hours in culture
The appearance of the explants at 120 hours resembled that of 72/96 hours (Figure 
4.12 and Figure 4.9). There were axon-like processes which had formed complex 
plexuses. However, following immunofluorescence there was no expression of 
Wtl found (Figure 4.13, A and B) and no expression of neural crest marker, SoxlO 
(4.13, C). This suggests that all NCCs had, by this point, either differentiated, 
many into neuronal cells as characterised by the expression Tujl (Figure 4.11), or 
had detached from the cover-slip due to cell death or agitation during the staining 
procedure. At 168 hours many cells had died or had floated away, and the neural 
tube piece had disintegrated quite significantly in comparison to 120 hour cultures 
(Figure 4.13, D and E). The remaining cells that were attached to the cover-slip at 
168 hours still possessed axonal processes and the general morphology of the cells 
was similar to that seen at earlier time-points. However there were fewer cells in 
the migratory population overall (Figure 4.13, F).
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4.5 Rate of migration of NCCs in vitro
To determine the rate at which NCCs migrated in vitro, neural tube explants were 
dissected and plated on cover-slips as previously described. Explants were then 
photographed at different time-points (24 and 48 hours), the margins of the 
explants were then demarcated and the distance between the margin and the 
migration front was measured (Figure 4.14). Seven explants were analysed at each 
time-point in order to determine the mean rate of migration and to account for the 
high degree of variability in migration rates between explants.
The results of this migration assay are shown in Table 4.1 and graphically in 
Figure 4.15. While these results reveal a clear trend in that NCCs do migrate 
further away from the central neural tube explant over time, there is considerable 
variability: The mean distance travelled by NCCs after 24 hours in culture was 139 
and the mean distance travelled after 48 hours was 304. The data revealed that 
NCCs have a mean rate of migration of 5.78pm/hour after 24 hours, increasing to 
6.34pm/hour after 48 hours (Figure 4.15).
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Table 4.2 Distance travelled by NCCs over a period of 48 horn's (pm). 
Measurements were taken at 24 hours and 48 hour’s. 0 hour's refers to the time at 
which the explants were placed into culture.
Sample 0 hours 24 hours 48 hours
1 0 160 359
2 0 133 266
3 0 133 293
4 0 146 359
5 0 133 293
6 0 146 320
7 0 120 239
Mean (pm) 0 139 304
Standard Deviation 0 12.9 45.1
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4.6 Wtl siRNA knock down of Wtl in kidney stem cells
This preliminary study was carried in order to test whether it would be possible to 
knock down Wtl, with the use of siRNA, in kidney stem cells (KSC, Figure 4.16), 
which are known to endogenously express high levels of Wtl (Davies, Ladomery 
et al. 2004; Fuente Mora, Ranghini et al. 2011). The successful application of this 
method in KSC could eventually be modified for use on neural tube explant 
cultures in order to elucidate the potential role for Wtl in early developing NCCs.
In order to confirm that the KSC expressed Wtl, immunofluorescence was earned 
out as previously described using the polyclonal Wtl antibody, which has been 
utilised throughout this thesis. The results of these experiments confirmed that 
KSC do indeed express Wtl as Wtl was shown to be expressed in the cell nucleus 
every KSC in the field of view (Figure 4.17).
Three samples of KSC were prepared. Each of the three samples was treated with 
one of the following conditions:
• Transfection with Wtl siRNA (Qiagen)
• Transfection with control siRNA (Qiagen)
• Transfection solution containing no siRNA
Once the experiment was completed the KSC were fixed and immunofluorescence 
was performed, the results are shown in Figure 4.18. Wtl expression did seem to 
have been repressed to a certain degree in the Wtl siRNA condition (Figure 4.18, 
A) compared to the control conditions (Figure 4.18, B and C). However, this is 
unconfirmed as in the time frame these experiments were carried out in it was not
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possible to introduce a system whereby you could determine how much Wtl 
expression had been repressed.
4.7 Conclusion
The results presented in this chapter demonstrate that neural tube cultures can be 
established in vitro and that NCCs do migrate away from the explant. Around half 
of migrating cells did express Wtl up to 96 hour's in culture but it was then down- 
regulated at subsequent time-points. This matched the results revealed from in vivo 
studies as Wtl was shown to be expressed in around half of the migrating 
population of NCCs in the E8.5 mouse embryo and was then down-regulated from 
E9.5. The significant difference in vivo and in vitro studies is that Wtl was still be 
detected in NCCs after 4 days in culture, whereas Wtl ceased to be expressed in 
NCCs in vivo within 24 hours.
The cultures were not optimised for long term culture and so explants and their 
migrating cells were unable to be maintained past seven days. This is possibly 
because a basic medium containing only serum with no growth factors was used 
throughout these studies. However this is not necessarily important as migration 
data gathered within the first 48 hours is sufficient for studying migration patterns.
It could be argued that the Wtl siRNA experiments did repress Wtl expression to 
a certain extent, due to the antibody staining looking slightly less vibrant than in 
the control samples. However, this would need confirming in future projects.
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Figure 4.1 Optimising explant preparation
Image A shows a neural tube explant plated on a glass cover-slip, coated in 
fibronectin. Image B shows a neural tube explant plated on a glass cover-slip, 
coated in poly-L-lysine. Both images were taken after 24 hours in culture with 
DMEM + 10% FCS. No cells can be seen emerging from either explant. The cells 
look dead. Scale bars 50pm.
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Figure 4.2 Optimising culture conditions of neural tube explants
A-C Neural tube explant after 48 hours in culture with DMEM + 10% FCS. A and 
D are phase contrast images taken with a lOx objective. Images B, C, E and F are 
phase contrast images taken with 40x objective. The cells contain a large number 
of vacuoles (B and C, arrows). D-F show neural tube explants after 48 hour’s in 
culture with DMEM + 5% FCS and 5% horse serum. Cells have visibly less 
vacuoles (E and F). Scale bars 200pm (A and D) 50pm (B, C, E and F).
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Figure 4.3 Confirmation that migrating cells are NCCs
Immunofluorescence was carried out on neural tube explant using antibodies 
against neural crest markers. A shows a bright-field image of B and C. DAPI is 
shown in image B. Image C show staining for SoxlO (red). These images were 
taken with a lOx objective after 96 hours in culture. Image D was taken with a lOx 
objective. It show the negative control for Alexa 568 donkey anti-goat (D). There 
was no unspecific staining seen in the control. This was the case throughout these 
studies, unless otherwise stated, nt - site of neural tube explant. This has detached 
from the underlying coverslip due to staining procedure. Scale bars 200pm.
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Figure 4.4 Wtl is expressed in NCCs after 24 hours in culture
Images A-C were taken with a 20x objective. Images D-F were taken with a 40x 
objective. Image A and D were taken using bright-field. Images B, C, E and F 
show Wtl (green) expressed in migrating NCCs from the neural tube explant 
(arrows). The nuclear stain DAPI (blue) is show in C and F. nt - Site of neural tube 
explant which is no longer attached to the coverslip after the staining procedure. 
Scale bars 50pm (A-C) 25pm (D-F).
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Figure 4.5 Characterisation of NCCs after 24 hours in culture
Image A was taken with a lOx objective. The images in B were taken with a 40x 
objective. All images were taken using phase contrast. The areas inside the yellow 
boxes show examples of an expanse of flattened epithelial cells (A, B, C and D) 
emerging from the central neural tube piece. Cells with multiple processes (B, E, F 
and G, arrows) can be seen migrating away from the neural tube explant, nt - site 
of neural tube explant Scale bars 200pm (A) 50pm (B).
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Figure 4.6 Immunofluorescence after 24 hours in culture
Images A-D show antibody staining of neural crest cell markers p75 (green, B and 
C) and Sox 10 (red, B and D) after 24 hours in culture. Image A was taken using 
brightfield. Image B is a composite image showing expression of P75 (C) and 
Sox 10 (D). The yellow arrows illustrate cells that co-express both P75 and Sox 10. 
DAPI is shown in blue (B-D). All images were taken with a 40x objective. Scale 
bars 25pm.
150
Figure 4.7 NCCs after 48 hours in culture
A-F are brightfield images of neural crest explants taken after 48 hours in culture. 
A was taken with a lOx objective and B-F were taken with a 40x objective. The 
area inside the yellow box (A) depicts the epithelial sheet at the outer margin of the 
neural tube explant. The arrow shows cell with multiple processes migrating away 
from the central piece (F). The arrowheads indicate axon-like processes arising 
from the NCCs. nt, site of neural tube explant. Scale bars 200pm (A) 50pm (B-F).
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Figure 4.8 Neural tube cultures after 48hrs in culture
Immunofluorescence was canied our using the polyclonal antibody for Wtl (B and 
C). E and F show immunofluorescence using the monoclonal antibody for Tujl. 
All images were taken with a 40x objective. A and D are bright-field images. 
Arrowheads demarcate axonal-like processes. Wtl staining is seen in the nuclei 
(arrows, A-C). Tujl staining is seen in differentiating neuronal cells (E and F). 
DAPI is shown in blue (C and F). Scale bar's 50pm.
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Figure 4.9 NCCs after 72 hours in culture
Image A was taken with a lOx objective. Cells have elongated processes and/or 
axonal-like projections. The central explant piece has begun to disintegrate. Image 
B and C were taken with a 40x objective. Image B shows cells that look to have 
recently divided (arrows). Image C shows axonal-like processes forming complex 
networks indicative of a neuronal plexus (box), nt, site of neural tube explant. 
Scale bars 200pm (A) 50pm (B and C).
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Figure 4.10 Immunofluorescence after 96 hours in culture
A and B are immunofluorescence images using a Wtl antibody taken with a lOx 
objective (green, arrows). A shows Wtl staining only. B shows Wtl and DAPI. C- 
E show immunofluorescence images using antibodies again Wtl and Sox 10 taken 
with a 40x objective. C shows Wtl expression only. D shows SoxlO expression 
only. E is a composite image showing Wtl and SoxlO with DAPI. Wtl and SoxlO 
are expressed together in some cells (arrowheads, C-E). nt, site of neural tube 
explant. Scale bars 200pm (A and B) 25pm (C-E).
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Figure 4.11 Immunofluorescence after 72 hours in culture
A and B were taken with a 40x objective. A is a bright-field image showing 
axonal-like projections (arrowheads). B shows antibody staining for the neuronal 
marker Tujl in the axonal processes, nt, site of neural tube explant. Scale bars 
50pm.
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Figure 4.12 NCCs after 120 hours in culture
A is a bright-field image taken with a 10 objective. B and C are bright-field images 
taken with a 40x objective. Axonal processes in complex networks (A-C, 
arrowheads). Scale bars 200pm (A) 50pm (B and C).
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Figure 4.13 Neural tube explants after 120 hours and 168 hours in culture
A-C were captured from immunofluorescence experiments taken with a lOx 
objective using Wtl and SoxlO antibodies after 120 hours. Image A shows the cell 
nuclei stained with DAPI. B shows Wtl staining only. C shows SoxlO staining 
only. There is no specific staining of Wtl and SoxlO (B and C). The arrows 
indicate a clump of cells which are fluorescent with both the red and green 
microscope filters. This does not appear to be specific staining (A-C). D and E are 
bright-field images taken with a lOx objective after 120 hours (D) and 168 hours 
(E). There are fewer cells after 168 hours and neural tube explant appears to have 
atrophied (E) in comparison with the neural tube explant at 120 hours (D). F is a 
bright-field image taken with a 40x objective after 168 hours in culture. Axonal 
processes are present (arrowheads) but there are fewer cells overall. NT, site of 
neural tube explant. Scale bars 50pm (A) 200pm (B-F).
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Figure 4.14 Measuring the distance traveiled of migrating NCCs
This figure is a schematic diagram representing a typical neural tube explant (NT) 
in culture. The distance travelled by NCCs in culture was measured from the 
margin of the explant to the migration front in pm. This was measured at 24 hours 
and 48 hours after being placed in culture. 7 samples were measured in order to 
produce an average distance travelled by NCCs over time in culture.
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Figure 4.15 Distance travelled by migratory NCCs in culture
The graph shows data collected from the NCC migration assay with an N number 
of 7. Explants were photographed at 24 and 48 hours after explants were placed in 
culture (time 0). At 24 hours the NCCs had migrated a mean distance of 138.7143, 
which gave the cells a rate of migration of 5.78pm/hour. At 48 hours the NCCs 
had migrated a mean distance of 304.1429 with a rate of migration of 
6.34pm/hour. Error bars represent the standard error.
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Figure 4.16 Kidney stem cells in culture
The bright field image shows KSC taken with a lOx objective after 24 hours in 
culture. Once the cells had reached 70% confluence they were ready for 
transfection with siRNAs. Scale bar 200gm.
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Figure 4.17 KSC express high levels of Wtl
Images A-D show KSC which underwent immunofluorescence using the 
polyclonal Wtl antibody in order to confirm that they did express Wtl. Image A is 
bright field, image B shows DAPI staining, image C show's Wtl expression within 
the nuclei of the KSC, and image D show the overlay between DAPI (B) and Wtl 
(C). Images were taken with a 40x objective. Scale bar SOpm.
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Figure 4.18 siRNA repression of Wtl in KSC
Each set of images (A-C) in this figure show KSC post-transfection with siRNAs 
or controls which have been fixed and prepared for immunofluorescence to see if 
Wtl expression had been repressed. Each set shows bright field image, an overlay 
of DAPI and Wtl, and Wtl alone. Image set A shows KSC treated with Wtl 
siRNA. Images set B show KSC treated with control SiRNA. Image set C shows 
KSC treated with the transfection media minus any SiRNA. Image set D is a 
negative control for the antibody showing KSC treated with siRNA but not 
incubated with primary antibody during the staining procedure. This was carried 
out for each of the three conditions and no unspecific staining was found. Scale bar 
50 pm.
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Chapter 5
Discussion
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This thesis aimed to establish a time-point at which Wtl was expressed in 
developing mouse NCCs, due to results of lineage tracing experiments, by 
systematically examining mouse embryos with the use of immunohistochemical 
and in situ hybridisation techniques. I also aimed to characterise the behaviour of 
vagal level NCCs in vitro and set up SiRNA experiments to knock down Wtl in 
cells where Wtl is known to be highly expressed, kidney stem cells, with the view 
to eventually using this in vitro/siRNA system on vagal NCCs in an attempt to 
establish a functional correlation between the Wtl gene, and the development of 
the ENS. Throughout my studies I have shown that Wtl protein and mRNA can be 
detected in NCCs of developing mouse embryos with the use of 
immunohistochemistry and in situ hybridisation both in vivo and in vitro. These 
aims were achieved and the findings have led me to the following conclusions, 
which will help direct future projects:
The expression pattern of Wtl in mouse embryonic development has been 
described in depth in the literature from E9.0 onwards (Pritchard-Jones, Fleming et 
al. 1990; Pelletier, Schalling et al. 1991; Armstrong, Pritchard-Jones et al. 1993; 
Kreidberg, Sariola et al. 1993; Park, Schalling et al. 1993; Moore, Schedl et al. 
1998; Moore, Mclnnes et al. 1999). My results correspond with Wtl expression 
patterns described in this literature between the stages of E9.5 and El 6.5. Thus, the 
novelty of my results resides in the expression pattern of Wtl during earlier 
periods of embryogenesis. Here I will discuss the expression of Wtl prior to E9.0 
as shown by my data in the previous results chapters, and express ideas for the 
potential role Wtl has in NCCs and ENS precursors.
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In my analysis I could show that Wtl and Sox 10 are co-expressed in 
approximately a quarter of the number of NCCs when they begin their migration 
away from the neural crest at E8.5 in the mouse embryo. This observation suggests 
that a subpopulation of ENS precursors is derived from Wtl-expressing cells. This 
novel finding may account for LacZ staining found within the ENS of adult Wtl- 
Cre mice (Wilm, Ipenberg et al. 2005) and co-staining of Wtl-derived J3-Gal and 
the neuronal marker Hu in newborn Wtl-Cre mouse ENS (Wilm, unpublished). In 
order to investigate this finding further a conditional, inducible Cre system could 
be employed, in which a drug-inducible Wtl-driven Cre can be activated at an 
early embryonic stage. The drug used in this system is Tamoxifen (Danielian, 
Muccino et al, 1998; Hayashi and McMahon 2002). This mouse could then be 
mated with the Rosa26 reporter (Soriano 1999) or another reporter mouse line. 
Only on administration of Tamoxifen would Cre become active and recombination 
could take place. This could be performed at varying stages during embryogenesis 
and the resulting staining would reveal information about when the Cre was 
activated, even once Wtl was no longer expressed by NCCs.
One of my findings was detection of Wtl at E7.5 in the mouse embryo. However, 
co-staining for Wtl and Sox 10, in order to test whether Wtl could be highlighting 
emerging NCCs, revealed no expression of Sox 10 at this embryonic stage. Sox 10 
is reported to be expressed from E8.5 onwards, when NCCs delaminate from the 
neural crest and begin their migration throughout the embryo (Hong and Saint- 
Jeannet 2005). Therefore, the data collected from these immunofluorescence 
experiments, which showed no SoxlO expression at E7.5 were to be expected and
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correspond to what is already known about Sox 10 expression in the developing 
mouse embryo.
My results revealed that Wtl expression was confined to a subpopulation of 
Sox 10-expressing NCCs at E8.5 in the mouse. It would be important to determine 
which particular NCC subset was expressing Wtl at this time-point. Could it be 
that Wtl is only expressed in certain neurons, such as nitric oxide synthase (NOS) 
neurons or calcitonin gene-related peptide (CGRP) neurons, and is Wtl expressed 
in glial cells (Figure 5.1)? Determining the specific neural crest-derived lineage 
that Wtl is expressed in would enable us to establish if the migratory potential or 
phenotype of these cells is disrupted or changed in Wtl mutant lines.
My finding that Wtl and SoxlO are co-expressed in NCCs raises an interesting link 
to another member of the Sox gene family, the Sox9 gene, Sox9 has been shown to 
be regulated by Wtl during testis development (Gao, Maiti et al. 2006). There is a 
conserved region 5’ of Sox9, which includes a putative binding site for Wtl 
(Bagheri-Fam, Ferraz et al. 2001). Importantly, Sox9 is expressed in NCCs at the 
same time, E8.5, as SoxlO in the mouse as NCCs begin their migration throughout 
the embryo into their different lineages (Hong and Saint-Jeannet 2005). It would be 
interesting to investigate the SoxlO protein and determine if this too has a putative 
binding site for Wtl. If this was the case it would further support my findings 
showing co-expression of Wtl and SoxlO in NCCs. It could also serve as an aid 
for investigating a role of Wtl in NCCs and ENS development. A conditional 
knock-out system could be employed using the Cre-LoxP system where Wtl
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would be conditionally knocked-out in Sox 10-expressing cells. Analysis of this 
could determine a role for Wtl in a subset of cells in the ENS.
The Wtl monoclonal antibody and the Wtl polyclonal antibody both were able to 
delineate the same expression pattern when used on tissue sections generated from 
mouse embryos between the embryonic ages of E9.5 and El6.5. However, the 
monoclonal Wtl antibody was unable to detect a specific signal for Wtl prior to 
E9.5. This finding meant I was only able to use the polyclonal Wtl antibody in 
immunofluorescence experiments at E8.5 and E7.5. The question that arises from 
this observation is: Why is there a difference between the two antibodies at early 
embryonic time-points? One explanation could be that the staining seen at E8.5 
and E7.5 is an artefact. However the same expression pattern was observed each 
time this experiment was performed on both embryos from the same litter and 
embryos taken from different litters. The expression was nuclear with some 
cytoplasmic expression, which corresponds to the literature on intracellular 
localisation of Wtl within a cell (Rauscher, Morris et al. 1990; Morris, Madden et 
al. 1991; Pelletier, Schalling et al. 1991; Bickmore, Oghene et al. 1992; Niksic, 
Slight et al. 2004). Furthermore, RNA in situ hybridisation experiments also 
detected Wtl activity in the neural crest region at E8.5 and in some cells of all 3 
germ layers at E7.5. Taken together these data suggest that Wtl staining performed 
with the Wtl polyclonal antibody is not artifactual and that there must be an 
alternative explanation for the differential pattern of Wtl staining with the two 
Wtl antibodies at early embryonic stages.
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The answer to this quandary may lie in one of the many Wtl protein isoforms 
generated by the numerous alternative splicing events found in the Wtl gene. The 
rabbit polyclonal Wtl antibody (C-19, Santa Cruz) was raised against peptides at 
the C-terminus of the Wtl protein. However, the mouse monoclonal Wtl antibody 
(6F-H2, Upstate) was raised against the N-terminus of the Wtl protein. Alternative 
splicing has been found to occur in exon one of the Wtl gene. As a result a shorter 
Wtl protein isoform is produced known as AWT1 (Dallosso, Hancock et al. 2004). 
It is therefore possible that the monoclonal Wtl antibody corresponds to peptides 
which were absent due to alternative splicing in exon 1. Thus it is important to 
establish if AWT1 is expressed in mouse embryos prior to E9.5. If this is the case 
it would provide a potential explanation as to why it is not possible to detect a 
specific signal at E8.5 with the monoclonal Wtl antibody. In order to establish if 
AWT1 is expressed, RT-PCR using specific primers for Wtl exon 1 and AWT1 
alternative exon 1 could be employed. I have made some preliminary 
investigations into this but was unable to optimise the experimental conditions in 
time and therefore could not make a conclusion. The preliminary data suggested 
that both Wtl and AWT1 were being expressed at E8.5 as a band was found for 
both transcripts. However further work would be needed to confirm if this was in 
fact the case.
A recent study revealed the -KTS Wtl isoform has a direct function in regulating 
EMT during the development of coronary vasculature using a conditional Wtl- 
knockout mouse generated by mating WtlGFP/+ and Gata5-Cre (Martinez-Estrada, 
Lettice et al. 2010). The resultant WtlLoxP/GFP mutant mice knocked-out Wtl 
specifically in epicardial cells and embryonic death occurred between El6.5 and
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El8.5 due to cardiovascular malformation (Martinez-Estrada, Lettice et ai. 2010). 
It has long been hypothesised that Wtl has a role in the processes of EMT and 
MET (Armstrong, Pritchard-Jones et al. 1993; Kreidberg, Sariola et al. 1993; 
Moore, Schedl et al. 1998; Moore, Mclmies et al. 1999). There is now evidence 
that Wtl regulates the transcription of key factors in EMT, snail and E-cadherin 
(Martinez-Estrada, Lettice et al. 2010). EMT is known to be a critical process in 
the formation of the development of the neural crest from which the ENS is 
derived (Duband, Monier et al. 1995; Sakai and Wakamatsu 2005). This process is 
controlled by a balance between E-cadherin and Snail (Cano, Perez-Moreno et al. 
2000). Three potential binding sites for Wtl have been indentified as conserved 
regions on the Snail (Snail) gene. My data presented in this thesis revealed Wtl is 
expressed in the neural crest at E8.5. It could be possible that Wtl plays a role in 
the process of EMT through the regulation of E-cadherin and Snail in NCC 
delamination as was shown by Martinez-Estrada in the case of coronary 
vasculature development. However Wtl appeal’s not to be expressed in all NCCs 
and phenotypes related to NCC developmental deficiencies in the mutant mouse 
have not been described.
As part of Martinez-Estrada5s study into the role of Wtl in EMT a Tamoxifen- 
inducible Wtl-knockout was generated in immortalised epicardial cells (Martinez- 
Estrada, Lettice et al. 2010). The in vitro results were similar to the results 
Martinez-Estrada saw in the conditional Wtl-knockout mouse. Snail was down- 
regulated and E-cadherin up-regulated after tamoxifen administration in order to 
induce the Wtl knockout in a dose-dependent manner (Martinez-Estrada, Lettice et 
al. 2010). This suggested that the epicardial cells were remaining in an epithelial
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state and did not under go EMT to become motile mesenchymal cells. Scratch 
assays on these mutant cells revealed a decrease in migratory potential of 
epicardial cells after Wtl was knocked out when Tamoxifen was administered 
(Martinez-Estrada, Lettice et al. 2010). Could this be the link to Wtl within NCCs? 
Perhaps if Wtl has a role in EMT at the neural crest then early migratory potential 
of the subset of Wtl-expressing NCCs is affected and therefore these cells can not 
migrate in a normal manner within the developing ENS.
Further evidence for a role of Wtl in cell migration or cell dynamics as a whole 
comes from Dudnakova and her finding that cytoplasmic Wtl directly binds with 
the cytoskeletal molecule actin, which is vital for cell movement (Dudnakova, 
Spraggon et al. 2010). These studies do provide insight into a role for Wtl in cell 
motility and EMT. Therefore further investigation would be needed to confirm if 
Wtl is playing a similar role in NCCs, as I was unable to reach the stage where I 
could acquire a definite measurement for Wtl knock-down with the use of siRNA 
on NCCs in neural tube explants in vitro.
The results from my migration assays produced a mean distance travelled of 
139j.im in 24 hours and 304pm after 48 hours. These results gave a mean rate of 
migration for NCCs of 5.78pm/hour after 24 hours and 6.34pm/hour after 48 
hours. The mean rate of migration could be used as a bench mark for measuring 
migration in NCCs when Wtl is knocked-down. There is, however, a discrepancy 
between my migration data and that of the literature (Barlow, Wallace et al. 2008). 
The NCCs in my experiments migrated slower than those published by Barlow et 
al. however, this may be explained by the use of different species. My neural tube
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explants were taken from mouse embryos, whereas Barlow et al. worked on avian 
embryos.
One of my findings showed that NCCs could be maintained in a healthier condition 
when media composition was switched from DMEM plus 10% NCS to DMEM 
plus 5% NCS and 5% horse serum (Jaenisch 1985). This finding is supported by 
investigations made into in vitro culture of plaque-forming cells (PFC) (Levy 
1980). A greater number of PFC was shown to be obtained with the use of media 
supplemented with 5% horse serum and 5% NCS (Levy 1980).
Wtl was shown to be expressed in approximately half the number of cultured 
NCCs after 24 hours as pail of my in vitro study. This result corresponds to my 
findings in vivo where around half of Sox 10-expressing NCCs in the region of the 
neural crest, also expressed Wtl. The NCC marker p75 was also expressed by most 
of the cultured NCCs at this time-point providing evidence that these cells were 
neural crest-derived. A small population of p75-expressing cells co-expressed with 
SoxlO. Neural crest stem cells (NCSCs) are characterised by the expression of 
these two markers (Stemple and Anderson 1992; Bixby, Kruger et al. 2002; 
Kruger, Mosher et al. 2002; Wong, Paratore et al. 2006). NCSCs retain their 
developmental potential in multi-potent state and can undergo self renewal in adult 
tissues to replace lost or damaged cells. NCSCs have been isolated in a number of 
adult tissues including adult mouse gut (Kruger, Mosher et al. 2002). These cells 
have been shown to have the potential to give rise to enteric neurons and glia both 
in vivo and in vitro (Kruger, Mosher et al. 2002). It is important to determine if 
Wtl is expressed specifically in these NCSCs and would be interesting to
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investigate if Wtl could play a role in these cells, perhaps in self-renewal. 
Evidence of a role for Wtl in self-renewal stems from the finding of Wtl 
expression in normal human bone marrow (Baird and Simmons 1997). When Wtl 
was over-expressed in bone marrow cells an increased number of haematopoietic 
cells were observed but there was no increase in maturation of these cells (Nishida, 
Hosen et al. 2006). In the case of leukaemia the constitutive expression of Wtl in 
leukemic cell lines was shown to block differentiation and lead to the development 
of leukaemia (Svedberg, Chylicki et al. 1998). These studies suggest a role for Wtl 
in the self-renewal of cells.
I had aimed, in a preliminary study, to knock down Wtl with siRNA in KSC 
before eventually adapting this technique for use on vagal NCCs. The initial data 
gathered from this pilot experiment was not convincing enough with only 
immunofluorescence as a way of detennining how much, if any, Wtl had been 
repressed because it was simply showing Wtl protein expression and could reveal 
nothing at the mRNA level. siRNA would not necessarily be expected to result in 
complete loss of Wtl mRNA, and hence one would need to look at Wtl levels 
with/without knock-down with time and to use RT-PCR to see the timing of the 
effect on the RNA levels. Unfortunately time limitations meant I was unable to 
optimise this procedure and so this will have to be carried out in future projects.
Wtl seems to play many different functional roles throughout development. Many 
of these roles are yet to be determined. It will be interesting to see what function 
Wtl has in NCCs and ENS development. It would appeal' that even after 20 years
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of investigation and numerous important developments there is still a lot unknown 
about the multi-faceted Wtl protein and its many functions.
179
E1
0.
5 
m
id
qu
t 
E1
2.
5m
id
au
t 
E1
7.
5
180
Figure 5.1 Examples of neuronal subtypes in the developing ENS
Image adapted from Young, Ciampoli et al. 1999 showing the differentiation and 
the changes in gene/protein expression of NCCs. All NCCs are undifferentiated at 
El0.5 and express p75, Ret, Phox2b. Tyrosine hydroxylase (TH) is expressed in a 
subset of these cells. At El2.5 NCCs have begun to differentiate based on the 
differenced in marker expressed, a NOS neuron can be identified as NOS is 
expressed in this subtype and differentiating glial cells retain expression p75. At 
El7.5 specific subpopulations of neurons are observed again based on the marker 
they express, such as NOS and CGRP neurons (Young, Ciampoli et al. 1999).
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